Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) has been decreasing over past decades. However, given that CVD is still a major cause of death in patients with diabetes and that the risk of CVD in patients with T...
Saved in:
Published in | Metabolism, clinical and experimental Vol. 123; p. 154838 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) has been decreasing over past decades. However, given that CVD is still a major cause of death in patients with diabetes and that the risk of CVD in patients with T2DM is more than twice that in those without DM, there are still considerable challenges to the prevention of CVD in diabetes. Accordingly, there have been several research efforts to decrease cardiovascular (CV) risk in T2DM. Large-scale genome-wide association studies (GWAS) and clinical cohort studies have investigated the effects of factors, such as genetic determinants, hypoglycaemia, and insulin resistance, on CVD and can account for the unexplained CV risk in T2DM. Lifestyle modification is a widely accepted cornerstone method to prevent CVD as the first-line strategy in T2DM. Recent reports from large CV outcome trials have proven the positive CV effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with high CVD risk. Overall, current practice guidelines for the management of CVD in T2DM are moving from a glucocentric strategy to a more individualised patient-centred approach. This review will discuss the current epidemiologic trends of CVD in T2DM and the risk factors linking T2DM to CVD, including genetic contribution, hypoglycaemia, and insulin resistance, and proper care strategies, including lifestyle and therapeutic approaches.
•Despite a decreasing trend in incidence, cardiovascular disease (CVD) still remains the major complication of diabetes.•Evidence supports attributing unexplained CV risk in T2DM to genetic components, hypoglycaemia, and insulin resistance.•Intensive lifestyle modification and nutrient off-loading could be more appropriate than increasing medication dose.•In established CVD, GLP-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors should be considered. |
---|---|
AbstractList | With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) has been decreasing over past decades. However, given that CVD is still a major cause of death in patients with diabetes and that the risk of CVD in patients with T2DM is more than twice that in those without DM, there are still considerable challenges to the prevention of CVD in diabetes. Accordingly, there have been several research efforts to decrease cardiovascular (CV) risk in T2DM. Large-scale genome-wide association studies (GWAS) and clinical cohort studies have investigated the effects of factors, such as genetic determinants, hypoglycaemia, and insulin resistance, on CVD and can account for the unexplained CV risk in T2DM. Lifestyle modification is a widely accepted cornerstone method to prevent CVD as the first-line strategy in T2DM. Recent reports from large CV outcome trials have proven the positive CV effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with high CVD risk. Overall, current practice guidelines for the management of CVD in T2DM are moving from a glucocentric strategy to a more individualised patient-centred approach. This review will discuss the current epidemiologic trends of CVD in T2DM and the risk factors linking T2DM to CVD, including genetic contribution, hypoglycaemia, and insulin resistance, and proper care strategies, including lifestyle and therapeutic approaches.
•Despite a decreasing trend in incidence, cardiovascular disease (CVD) still remains the major complication of diabetes.•Evidence supports attributing unexplained CV risk in T2DM to genetic components, hypoglycaemia, and insulin resistance.•Intensive lifestyle modification and nutrient off-loading could be more appropriate than increasing medication dose.•In established CVD, GLP-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors should be considered. With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) has been decreasing over past decades. However, given that CVD is still a major cause of death in patients with diabetes and that the risk of CVD in patients with T2DM is more than twice that in those without DM, there are still considerable challenges to the prevention of CVD in diabetes. Accordingly, there have been several research efforts to decrease cardiovascular (CV) risk in T2DM. Large-scale genome-wide association studies (GWAS) and clinical cohort studies have investigated the effects of factors, such as genetic determinants, hypoglycaemia, and insulin resistance, on CVD and can account for the unexplained CV risk in T2DM. Lifestyle modification is a widely accepted cornerstone method to prevent CVD as the first-line strategy in T2DM. Recent reports from large CV outcome trials have proven the positive CV effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with high CVD risk. Overall, current practice guidelines for the management of CVD in T2DM are moving from a glucocentric strategy to a more individualised patient-centred approach. This review will discuss the current epidemiologic trends of CVD in T2DM and the risk factors linking T2DM to CVD, including genetic contribution, hypoglycaemia, and insulin resistance, and proper care strategies, including lifestyle and therapeutic approaches. |
ArticleNumber | 154838 |
Author | Ko, Seung-Hyun Yun, Jae-Seung |
Author_xml | – sequence: 1 givenname: Jae-Seung surname: Yun fullname: Yun, Jae-Seung – sequence: 2 givenname: Seung-Hyun surname: Ko fullname: Ko, Seung-Hyun email: kosh@catholic.ac.kr |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34333002$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE2LFDEQhoOsuLOrP0HJ0UuPlc_OnEQGv2DBi55DOqleMnYnY9K9MP_eDDN68OKlqqDe9y3quSM3KSck5DWDLQOm3x22My5uyNOWA2dbpqQR5hnZMCV4ZzTADdkAcN2B3KlbclfrAQD63ugX5FZIIUTbbkjar6VgWujSaqg0JorHGHCOecqPJ5pH6l0JMT-56tfJFRpiRVeRuhT-XZVYf9LZJfeI8zmzhS2nI1LeTG7ABetL8nx0U8VX135Pfnz6-H3_pXv49vnr_sND5yXjSxeMd0ztBAsGgmcSQLvRjVyMAbkcez4Y3sPA29RruRNaOmG0GgbpjZCDEPfk7SX3WPKvFeti51g9TpNLmNdquVK9kkIbaFJ1kfqSay042mOJsysny8CeUduDvaK2Z9T2grr53lxPrMOM4a_rD9smeH8RYHv0KWKx1UdMHkMs6BcbcvzPid8DlJUG |
CitedBy_id | crossref_primary_10_3390_diabetology4040050 crossref_primary_10_19161_etd_1180666 crossref_primary_10_2337_dc21_1921 crossref_primary_10_1016_j_metabol_2022_155332 crossref_primary_10_3390_biomedicines11102611 crossref_primary_10_4239_wjd_v14_i8_1146 crossref_primary_10_1002_jcph_2483 crossref_primary_10_1007_s11845_024_03744_z crossref_primary_10_1111_jdi_13818 crossref_primary_10_1186_s12933_022_01531_7 crossref_primary_10_4239_wjd_v15_i4_638 crossref_primary_10_1186_s12944_023_01936_7 crossref_primary_10_1055_s_0043_1770985 crossref_primary_10_1093_eurjpc_zwae117 crossref_primary_10_1111_jfbc_14130 crossref_primary_10_1186_s12933_023_01910_8 crossref_primary_10_4093_dmj_2021_0135 crossref_primary_10_1016_j_atherosclerosis_2023_117313 crossref_primary_10_1111_ajag_13282 crossref_primary_10_1016_j_molmet_2022_101531 crossref_primary_10_1186_s12933_022_01516_6 crossref_primary_10_1002_iid3_1036 crossref_primary_10_1016_j_bcp_2023_115976 crossref_primary_10_1016_j_jesf_2023_06_002 crossref_primary_10_1097_MJT_0000000000001689 crossref_primary_10_3389_fendo_2023_1251451 crossref_primary_10_14232_abs_2023_1_87_101 crossref_primary_10_3389_ijph_2022_1605064 crossref_primary_10_1136_bmjdrc_2023_003469 crossref_primary_10_1371_journal_pone_0305954 crossref_primary_10_7717_peerj_15226 crossref_primary_10_1111_1753_0407_13258 crossref_primary_10_1007_s11886_023_01906_6 crossref_primary_10_1186_s12933_024_02217_y crossref_primary_10_1002_ajim_23505 crossref_primary_10_3389_fendo_2022_961802 crossref_primary_10_1016_j_jdiacomp_2022_108390 crossref_primary_10_1016_j_peptides_2024_171203 crossref_primary_10_1159_000539001 crossref_primary_10_1016_j_jesf_2023_08_003 crossref_primary_10_1002_mnfr_202200077 crossref_primary_10_1016_j_inoche_2024_112103 crossref_primary_10_1186_s13098_024_01266_3 crossref_primary_10_5294_aqui_2022_22_3_7 crossref_primary_10_1007_s11010_022_04633_8 crossref_primary_10_3390_nu16060771 crossref_primary_10_1111_jcmm_17519 crossref_primary_10_1016_j_jep_2024_117792 crossref_primary_10_7759_cureus_51066 crossref_primary_10_1007_s00125_023_06074_4 crossref_primary_10_7759_cureus_43882 crossref_primary_10_3390_ijerph20054491 crossref_primary_10_1097_MD_0000000000033133 crossref_primary_10_1007_s10653_023_01604_w crossref_primary_10_3390_nu15081978 crossref_primary_10_36011_cpp_2022_4_e13 crossref_primary_10_1016_j_ijcrp_2024_200265 crossref_primary_10_7759_cureus_37708 crossref_primary_10_1111_jnc_15996 crossref_primary_10_1080_1061186X_2023_2295268 crossref_primary_10_3389_fmicb_2023_1121695 crossref_primary_10_3390_biomedicines12020314 crossref_primary_10_1016_j_pcd_2022_02_002 crossref_primary_10_2147_DDDT_S418321 crossref_primary_10_1016_j_advnut_2023_04_009 crossref_primary_10_14710_jgi_11_2_110_118 crossref_primary_10_3389_fendo_2022_1078686 crossref_primary_10_1016_j_diabres_2024_111121 crossref_primary_10_1080_27694127_2024_2330327 crossref_primary_10_1080_14779072_2023_2174102 crossref_primary_10_1016_j_phymed_2024_155780 crossref_primary_10_3390_cimb44100328 crossref_primary_10_7759_cureus_51151 crossref_primary_10_3390_antiox13030277 crossref_primary_10_3389_fcvm_2023_1234271 crossref_primary_10_7759_cureus_43697 crossref_primary_10_1097_XCE_0000000000000306 crossref_primary_10_1002_ptr_7901 crossref_primary_10_1016_j_ejmech_2024_116325 crossref_primary_10_1016_j_numecd_2023_11_004 crossref_primary_10_2174_1871530323666230127121738 crossref_primary_10_3390_foods12193698 crossref_primary_10_3390_ijms24109085 crossref_primary_10_1097_MD_0000000000034394 crossref_primary_10_3390_jcm11154257 crossref_primary_10_1016_j_ecoenv_2022_114283 |
Cites_doi | 10.1186/s12933-021-01213-w 10.2196/11819 10.1016/j.cmet.2011.07.015 10.2337/dci19-0066 10.1038/nrendo.2014.29 10.1016/S2213-8587(13)70025-1 10.1111/dom.13112 10.1371/journal.pone.0053316 10.1001/jama.2017.0947 10.1056/NEJMoa1811744 10.1016/j.amepre.2019.08.014 10.1001/jama.2009.126 10.1186/s12933-018-0728-6 10.1161/CIRCULATIONAHA.108.829176 10.1093/eurheartj/ehv083 10.1136/bmj.b4909 10.1056/NEJMoa1310799 10.2337/dc06-0919 10.1016/j.pharmthera.2007.10.004 10.2337/dc12-0413 10.1161/JAHA.113.000582 10.1186/s12933-016-0490-6 10.1016/j.jacc.2010.10.063 10.1016/S0140-6736(12)60480-2 10.2337/diacare.25.7.1177 10.2337/dc17-2677 10.4093/dmj.2016.40.3.202 10.1056/NEJMoa0808431 10.1007/s00125-015-3525-8 10.1055/s-0038-1657180 10.2337/dc21-S004 10.1056/NEJMoa0802743 10.2337/diacare.29.01.06.dc05-0776 10.1177/0890117118816278 10.2337/dc18-1144 10.1161/01.CIR.0000057982.50167.6E 10.1056/NEJMoa2022190 10.2337/dc17-1778 10.1007/s11154-012-9229-1 10.2337/dc11-s220 10.1016/S0140-6736(18)32261-X 10.1177/2047487317750913 10.1186/1471-2350-12-146 10.1186/s12933-019-0828-y 10.1111/dom.12871 10.1093/eurheartj/ehaa082 10.1371/journal.pone.0052036 10.1056/NEJMoa1605086 10.1038/nrm2391 10.1007/s00125-020-05366-3 10.1249/MSS.0000000000000198 10.1016/S0140-6736(08)60766-7 10.1056/NEJMoa1504720 10.2337/dc21-S006 10.1186/s12933-020-01010-x 10.1161/CIRCRESAHA.115.306825 10.2337/dc17-1669 10.1056/NEJMoa1607141 10.1056/NEJMoa1003795 10.1016/j.jacc.2016.11.076 10.2337/dc11-1162 10.1056/NEJMoa2030186 10.1152/ajpendo.00114.2007 10.1001/jamacardio.2018.1717 10.1093/gerona/glu194 10.1016/S0140-6736(16)30506-2 10.1056/NEJMoa1611925 10.1056/NEJMoa1509225 10.1056/NEJMoa1608664 10.2337/dc16-2625 10.1002/ejhf.657 10.1016/j.jacc.2018.04.027 10.1056/NEJMoa1812389 10.1056/NEJMoa1603827 10.2337/dc09-2082 10.1177/1358863X12450094 10.1007/s00125-013-3063-1 10.1001/jama.2016.19720 10.1016/S0140-6736(18)30314-3 10.2337/dc19-S006 10.4093/dmj.2018.0070 10.2337/dci17-0025 10.2337/dc20-0256 10.1056/NEJMoa1612917 10.1038/ng.3914 10.1001/jama.280.21.1843 10.1016/j.jacc.2018.07.061 10.1038/s41588-018-0241-6 10.2147/CLEP.S169835 10.1056/NEJMoa1901118 10.1161/CIRCULATIONAHA.115.015293 10.1136/openhrt-2019-001017 10.2337/dc09-2110 10.2337/dc11-0735 10.2337/dci18-0007 10.1038/oby.2003.123 10.2337/diacare.25.7.1135 10.1016/j.jacc.2016.06.049 10.1097/HJH.0b013e3283340da8 10.1016/j.jacc.2014.04.058 10.1056/NEJMoa1911303 10.1001/jamacardio.2020.4511 10.1016/j.mayocp.2013.11.005 10.2337/dc18-0836 10.1016/S0140-6736(06)69700-6 10.1056/NEJMoa0706245 10.2337/dc20-0552 10.4093/dmj.2020.0175 10.2337/db19-0097 10.1016/S2213-8587(20)30110-8 10.2174/1573402110666140812122349 10.1016/j.metabol.2008.10.018 10.1016/j.cell.2011.04.005 10.1161/ATVBAHA.116.307612 10.2337/dc17-1638 10.1016/j.jacc.2008.04.016 10.2337/diacare.26.5.1513 10.1186/s12933-019-0909-y 10.2337/dc16-0985 10.1038/ncomms8060 10.1001/jama.2016.10260 10.1186/1471-2350-14-11 10.2337/dc18-0831 10.1056/NEJMoa1800256 10.1093/eurheartj/eht332 10.1016/S0140-6736(19)31149-3 10.1161/CIRCULATIONAHA.120.046783 10.1002/ejhf.1673 10.2337/diabetes.54.11.3252 10.1161/CIRCRESAHA.117.312086 10.1002/sim.3034 10.1161/CIR.0b013e3182285a81 10.1161/JAHA.115.002875 10.1007/s00125-017-4422-0 10.1161/01.ATV.0000215951.36219.a4 10.1186/s12933-016-0482-6 10.1016/S0009-9120(03)00078-X 10.2337/db14-0694 10.1161/ATVBAHA.113.300156 10.1056/NEJMoa2004967 10.2337/diacare.29.02.06.dc05-1700 10.1016/S0140-6736(19)32008-2 |
ContentType | Journal Article |
Copyright | 2021 The Author(s) Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2021 The Author(s) – notice: Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.metabol.2021.154838 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1532-8600 |
EndPage | 154838 |
ExternalDocumentID | 10_1016_j_metabol_2021_154838 34333002 S0026049521001384 |
Genre | Journal Article Review |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 6I. 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAFTH AAFWJ AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO AAYJJ ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q G8K GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W J5H K-O KOM L7B LCYCR LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OB0 OHT ON- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UAP UHS WUQ X7M Z5R ZA5 ZGI ~G- ~KM CGR CUY CVF ECM EIF NPM 0SF AAXKI AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c412t-d8ca15931d80dc14006afaf23fde24f72b8270b2f727649364a3865bb4c834b33 |
IEDL.DBID | .~1 |
ISSN | 0026-0495 |
IngestDate | Fri Aug 16 04:55:53 EDT 2024 Thu Sep 12 17:37:58 EDT 2024 Thu May 23 23:37:25 EDT 2024 Fri Feb 23 02:39:01 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Type 2 diabetes Cardiovascular disease Genetics Insulin resistance Lifestyle modification Hypoglycaemia |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c412t-d8ca15931d80dc14006afaf23fde24f72b8270b2f727649364a3865bb4c834b33 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0026049521001384 |
PMID | 34333002 |
PQID | 2557543680 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2557543680 crossref_primary_10_1016_j_metabol_2021_154838 pubmed_primary_34333002 elsevier_sciencedirect_doi_10_1016_j_metabol_2021_154838 |
PublicationCentury | 2000 |
PublicationDate | October 2021 2021-10-00 20211001 |
PublicationDateYYYYMMDD | 2021-10-01 |
PublicationDate_xml | – month: 10 year: 2021 text: October 2021 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Metabolism, clinical and experimental |
PublicationTitleAlternate | Metabolism |
PublicationYear | 2021 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Rashid, Watanabe, Sakaue, Lewis (bb0430) 2003; 36 Desouza, Bolli, Fonseca (bb0340) 2010; 33 Coorey, Neubeck, Mulley, Redfern (bb0595) 2018; 25 Danaei, Lawes, Vander Hoorn, Murray, Ezzati (bb0020) 2006; 368 Messner, Bernhard (bb0540) 2014; 34 Simonson, Wills, Keller, McQueen (bb0185) 2011; 12 Gregg, Cheng, Saydah, Cowie, Garfield, Geiss (bb0030) 2012; 35 Gaede, Lund-Andersen, Parving, Pedersen (bb0135) 2008; 358 Duckworth, Abraira, Moritz, Reda, Emanuele, Reaven (bb0245) 2009; 360 Gregg, Cheng, Srinivasan, Lin, Geiss, Albright (bb0090) 2018; 391 Jorsal, Kistorp, Holmager, Tougaard, Nielsen, Hänselmann (bb0710) 2017; 19 Marsico, Paolillo, Gargiulo, Bruzzese, Dell’Aversana, Esposito (bb0060) 2020; 41 Pieber, Marso, McGuire, Zinman, Poulter, Emerson (bb0335) 2018; 61 Gast, Tjeerdema, Stijnen, Smit, Dekkers (bb0485) 2012; 7 Shariful Islam, Farmer, Bobrow, Maddison, Whittaker, Pfaeffli Dale (bb0600) 2019; 6 Lawlor, Harbord, Sterne, Timpson, Davey (bb0220) 2008; 27 Laakso, Kuusisto (bb0390) 2014; 10 Salas-Salvadó, Díaz-López, Ruiz-Canela, Basora, Fitó, Corella (bb0590) 2019; 42 Han, Yun, Park, Ahn, Cho, Cha (bb0370) 2018; 10 Guilherme, Virbasius, Puri, Czech (bb0410) 2008; 9 Nolan, Ruderman, Kahn, Pedersen, Prentki (bb0535) 2015; 64 Einarson, Acs, Ludwig, Panton (bb0165) 2018; 17 Marso, Daniels, Brown-Frandsen, Kristensen, Mann, Nauck (bb0670) 2016; 375 Yusuf, Joseph, Rangarajan, Islam, Mente, Hystad (bb0050) 2020; 395 Bayoumy, Gaber, Elshafeey, Mhaimeed, Dineen, Marvel (bb0570) 2021 Holman, Bethel, Mentz, Thompson, Lokhnygina, Buse (bb0675) 2017; 377 Bonora, Formentini, Calcaterra, Lombardi, Marini, Zenari (bb0375) 2002; 25 Vergès (bb0425) 2015; 58 Zhou, Schulman, Raij (bb0450) 2010; 28 Perkovic, Jardine, Neal, Bompoint, Heerspink, Charytan (bb0635) 2019; 380 Brickwood, Watson, O’Brien, Williams (bb0610) 2019; 7 Packer, Anker, Butler, Filippatos, Pocock, Carson (bb0650) 2020; 383 Rivera, Carreras-Torres, Roncarati, Viviani-Anselmi, De Micco, Mezzelani (bb0190) 2013; 14 Gerstein, Ferrannini, Riddle, Yusuf (bb0530) 2018; 20 Muniyappa, Sowers (bb0455) 2013; 14 Marso, Bain, Consoli, Eliaschewitz, Jódar, Leiter (bb0665) 2016; 375 Razavi Nematollahi, Kitabchi, Stentz, Wan, Larijani, Tehrani (bb0350) 2009; 58 Hernandez, Green, Janmohamed, D’Agostino, Granger, Jones (bb0680) 2018; 392 de Jager, Dekker, Kooy, Kostense, Nijpels, Heine (bb0460) 2006; 26 Wilmot, O’Flaherty, Capewell, Ford, Vaccarino (bb0175) 2015; 132 Kang, Cho, Lee, Lee, Lee, Park (bb0065) 2019; 43 Qasim, Mehta, Tadesse, Wolfe, Rhodes, Girman (bb0505) 2008; 52 Peikes, Chen, Schore, Brown (bb0155) 2009; 301 Bornfeldt, Tabas (bb0420) 2011; 14 O’Connor, Bodkin, Fradkin, Glasgow, Greenfield, Gregg (bb0150) 2011; 34 Liu, Li, Hu, Zong, Li, Rimm (bb0035) 2018; 71 Moore, Tabas (bb0415) 2011; 145 Zhou, Schulman, Zeng (bb0440) 2012; 17 Bonora, Kiechl, Willeit, Oberhollenzer, Egger, Meigs (bb0385) 2007; 30 Gerstein, Colhoun, Dagenais, Diaz, Lakshmanan, Pais (bb0685) 2019; 394 Bragg, Holmes, Iona, Guo, Du, Chen (bb0170) 2017; 317 Hanley, Williams, Stern, Haffner (bb0380) 2002; 25 Cannon, Pratley, Dagogo-Jack, Mancuso, Huyck, Masiukiewicz (bb0645) 2020; 383 Amiel (bb0360) 2021; 64 Wiviott, Raz, Bonaca, Mosenzon, Kato, Cahn (bb0640) 2019; 380 Margulies, Hernandez, Redfield, Givertz, Oliveira, Cole (bb0715) 2016; 316 Giugliano, Longo, Scappaticcio, Caruso, Esposito (bb0055) 2021; 20 Standl, Stevens, Armstrong, Buse, Chan, Green (bb0270) 2018; 41 Mahajan, Taliun, Thurner, Robertson, Torres, Rayner (bb0195) 2018; 50 Wright, Suarez-Ortegon, Read, Kontopantelis, Buchan, Emsley (bb0120) 2020; 142 (bb0010) 2018; 41 Rawshani, Rawshani, Franzén, Eliasson, Svensson, Miftaraj (bb0080) 2017; 376 Chapman, Sposito (bb0395) 2008; 117 Neal, Perkovic, Mahaffey, de Zeeuw, Fulcher, Erondu (bb0625) 2017; 377 Smith, Duque, Huffman, Healy, Celano (bb0605) 2020; 58 Zinman, Wanner, Lachin, Fitchett, Bluhmki, Hantel (bb0620) 2015; 373 Bhupathiraju, Hu (bb0070) 2016; 118 Seferović, Coats, Ponikowski, Filippatos, Huelsmann, Jhund (bb0725) 2020; 22 (bb0365) 2021; 44 Stefan (bb0405) 2020; 8 Robins, Rubins, Faas, Schaefer, Elam, Anderson (bb0470) 2003; 26 (bb0005) 2017 Heller, Bergenstal, White, Kupfer, Bakris, Cushman (bb0330) 2017; 19 Said, Verweij, van der Harst (bb0580) 2018; 3 Gregg, Li, Wang, Burrows, Ali, Rolka (bb0075) 2014; 370 Bonds, Miller, Bergenstal, Buse, Byington, Cutler (bb0290) 2010; 340 Rawshani, Rawshani, Franzén, Sattar, Eliasson, Svensson (bb0115) 2018; 379 Lind, Garcia-Rodriguez, Booth, Cea-Soriano, Shah, Ekeroth (bb0095) 2013; 56 Gerstein, Miller, Byington, Goff, Bigger, Buse (bb0250) 2008; 358 Davis, Duckworth, Emanuele, Hayward, Wiitala, Thottapurathu (bb0260) 2019; 42 Lee, Warren, Lee, McEvoy, Matsushita, Huang (bb0315) 2018; 41 Kamide (bb0445) 2013; 9 O’Keefe, Bhatti, Bajwa, DiNicolantonio, Lavie (bb0545) 2014; 89 Lv, Yu, Guo, Bian, Yang, Chen (bb0040) 2017; 69 Cha, Yun, Lim, Hwang, Yim, Song (bb0295) 2016; 40 Bigaard, Tjønneland, Thomsen, Overvad, Heitmann, Sørensen (bb0510) 2003; 11 Preis, Hwang, Coady, Pencina, D’Agostino, Savage (bb0025) 2009; 119 Shah, Morieri, Marcovina, Sigal, Gerstein, Wagner (bb0210) 2018; 41 Zinman, Marso, Christiansen, Calanna, Rasmussen, Buse (bb0275) 2018; 41 Frier, Schernthaner, Heller (bb0265) 2011; 34 Khera, Emdin, Drake, Natarajan, Bick, Cook (bb0575) 2016; 375 Soinio, Marniemi, Laakso, Lehto, Rönnemaa (bb0465) 2006; 29 Jung, Chung, Han, Ko, Ko, Park (bb0100) 2017; 16 Weintraub, Daniels, Burke, Franklin, Goff, Hayman (bb0565) 2011; 124 Gerstein, Werstuck (bb0240) 2013; 1 Giugliano, De Nicola, Maiorino, Bellastella, Garofalo, Chiodini (bb0695) 2020; 19 Inzucchi, Bergenstal, Buse, Diamant, Ferrannini, Nauck (bb0280) 2012; 35 Beck, Greenwood, Blanton, Bollinger, Butcher, Condon (bb0145) 2017; 40 Sung, Choi, Gwon, Choi, Kim, Kwag (bb0500) 2013; 8 Bhatt, Szarek, Pitt, Cannon, Leiter, McGuire (bb0655) 2021; 384 Yun, Jung, Shivakumar, Xiao, Khera, Park (bb0215) 2021 Merino, Jablonski, Mercader, Kahn, Chen, Harden (bb0180) 2020; 69 Buse, Wexler, Tsapas, Rossing, Mingrone, Mathieu (bb0730) 2020; 43 (bb0285) 2019; 42 Lipska, Yao, Herrin, McCoy, Ross, Steinman (bb0125) 2017; 40 Yun, Park, Han, Cha, Ahn, Ko (bb0320) 2019; 18 Li, Zhang, Wang, Gregg, Yang, Gong (bb0585) 2008; 371 Tricco, Ivers, Grimshaw, Moher, Turner, Galipeau (bb0160) 2012; 379 Echouffo-Tcheugui, Daya, Lee, Tang, Ndumele, Windham (bb0300) 2021; 44 O’Donnell, Chin, Rangarajan, Xavier, Liu, Zhang (bb0560) 2016; 388 Pfeffer, Claggett, Diaz, Dickstein, Gerstein, Køber (bb0660) 2015; 373 Goto, Goto, Terauchi, Yamaguchi, Noda (bb0305) 2016; 5 Klarin, Zhu, Emdin, Chaffin, Horner, McMillan (bb0205) 2017; 49 Zoungas, Patel, Chalmers, de Galan, Li, Billot (bb0255) 2010; 363 Micha, Peñalvo, Cudhea, Imamura, Rehm, Mozaffarian (bb0045) 2017; 317 McGuire, Shih, Cosentino, Charbonnel, Cherney, Dagogo-Jack (bb0130) 2021; 6 Sommerfield, Wilkinson, Webb, Frier (bb0355) 2007; 293 Park, Ha, Kim, Lee, Kim (bb0105) 2021; 45 Ross, Gerstein, Eikelboom, Anand, Yusuf, Paré (bb0225) 2015; 36 Vakkilainen, Steiner, Ansquer, Aubin, Rattier, Foucher (bb0435) 2003; 107 Singh, Danaei, Farzadfar, Stevens, Woodward, Wormser (bb0015) 2013; 8 McMurray, Solomon, Inzucchi, Køber, Kosiborod, Martinez (bb0630) 2019; 381 Katzmarzyk (bb0555) 2014; 46 Li, Xu, Wan, Shen, Xu, Zhao (bb0515) 2020; 43 Kim, Lee, Lee, Kim, Jacobs, Lee (bb0490) 2015; 70 van der Harst, Verweij (bb0200) 2018; 122 Yamazoe, Hisamatsu, Miura, Kadowaki, Zaid, Kadota (bb0495) 2016; 36 Després (bb0525) 2011; 57 Cefalo, Cinti, Moffa, Impronta, Sorice, Mezza (bb0700) 2019; 18 (bb0140) 2021; 44 Rexrode, Carey, Hennekens, Walters, Colditz, Stampfer (bb0520) 1998; 280 Lee, Pate, Lavie, Sui, Church, Blair (bb0550) 2014; 64 Lee, McEvoy, Hoogeveen, Ballantyne, Selvin (bb0310) 2016; 68 Booth, Kapral, Fung, Tu (bb0085) 2006; 29 Fitzgibbons, Czech (bb0400) 2014; 3 Mellbin, Rydén, Riddle, Probstfield, Rosenstock, Díaz (bb0325) 2013; 34 Husain, Birkenfeld, Donsmark, Dungan, Eliaschewitz, Franco (bb0690) 2019; 381 Lorenz, Lawson, Owens, Raccah, Roy-Duval, Lehmann (bb0720) 2017; 16 Cheng, Imperatore, Geiss, Saydah, Albright, Ali (bb0110) 2018; 41 Ahmad, Morris, Mujammami, Forgetta, Leong, Li (bb0230) 2015; 6 Dalsgaard-Nielsen, Madsbad, Hilsted (bb0345) 1982; 47 Ausk, Boyko, Ioannou (bb0480) 2010; 33 Kirk, Amiri, Pirbaglou, Ritvo (bb0615) 2019; 33 Rutter, Meigs, Sullivan, D’Agostino, Wilson (bb0475) 2005; 54 Merino, Leong, Posner, Porneala, Masana, Dupuis (bb0235) 2017; 40 Seidelmann, Feofanova, Yu, Franceschini, Claggett, Kuokkanen (bb0705) 2018; 72 Lee (10.1016/j.metabol.2021.154838_bb0315) 2018; 41 Lipska (10.1016/j.metabol.2021.154838_bb0125) 2017; 40 Lind (10.1016/j.metabol.2021.154838_bb0095) 2013; 56 Desouza (10.1016/j.metabol.2021.154838_bb0340) 2010; 33 Buse (10.1016/j.metabol.2021.154838_bb0730) 2020; 43 Messner (10.1016/j.metabol.2021.154838_bb0540) 2014; 34 Duckworth (10.1016/j.metabol.2021.154838_bb0245) 2009; 360 Wilmot (10.1016/j.metabol.2021.154838_bb0175) 2015; 132 Merino (10.1016/j.metabol.2021.154838_bb0235) 2017; 40 Nolan (10.1016/j.metabol.2021.154838_bb0535) 2015; 64 Cheng (10.1016/j.metabol.2021.154838_bb0110) 2018; 41 Bragg (10.1016/j.metabol.2021.154838_bb0170) 2017; 317 Seidelmann (10.1016/j.metabol.2021.154838_bb0705) 2018; 72 Brickwood (10.1016/j.metabol.2021.154838_bb0610) 2019; 7 Liu (10.1016/j.metabol.2021.154838_bb0035) 2018; 71 Gaede (10.1016/j.metabol.2021.154838_bb0135) 2008; 358 Marsico (10.1016/j.metabol.2021.154838_bb0060) 2020; 41 Goto (10.1016/j.metabol.2021.154838_bb0305) 2016; 5 Zhou (10.1016/j.metabol.2021.154838_bb0440) 2012; 17 Jorsal (10.1016/j.metabol.2021.154838_bb0710) 2017; 19 Bhatt (10.1016/j.metabol.2021.154838_bb0655) 2021; 384 Husain (10.1016/j.metabol.2021.154838_bb0690) 2019; 381 Giugliano (10.1016/j.metabol.2021.154838_bb0695) 2020; 19 Bonora (10.1016/j.metabol.2021.154838_bb0385) 2007; 30 Lee (10.1016/j.metabol.2021.154838_bb0550) 2014; 64 Danaei (10.1016/j.metabol.2021.154838_bb0020) 2006; 368 Sung (10.1016/j.metabol.2021.154838_bb0500) 2013; 8 Preis (10.1016/j.metabol.2021.154838_bb0025) 2009; 119 Tricco (10.1016/j.metabol.2021.154838_bb0160) 2012; 379 Klarin (10.1016/j.metabol.2021.154838_bb0205) 2017; 49 Dalsgaard-Nielsen (10.1016/j.metabol.2021.154838_bb0345) 1982; 47 (10.1016/j.metabol.2021.154838_bb0365) 2021; 44 Cefalo (10.1016/j.metabol.2021.154838_bb0700) 2019; 18 Hanley (10.1016/j.metabol.2021.154838_bb0380) 2002; 25 Lv (10.1016/j.metabol.2021.154838_bb0040) 2017; 69 Soinio (10.1016/j.metabol.2021.154838_bb0465) 2006; 29 Bhupathiraju (10.1016/j.metabol.2021.154838_bb0070) 2016; 118 Bigaard (10.1016/j.metabol.2021.154838_bb0510) 2003; 11 Zhou (10.1016/j.metabol.2021.154838_bb0450) 2010; 28 Khera (10.1016/j.metabol.2021.154838_bb0575) 2016; 375 Li (10.1016/j.metabol.2021.154838_bb0585) 2008; 371 Perkovic (10.1016/j.metabol.2021.154838_bb0635) 2019; 380 Gregg (10.1016/j.metabol.2021.154838_bb0075) 2014; 370 Neal (10.1016/j.metabol.2021.154838_bb0625) 2017; 377 Gregg (10.1016/j.metabol.2021.154838_bb0090) 2018; 391 (10.1016/j.metabol.2021.154838_bb0010) 2018; 41 Shariful Islam (10.1016/j.metabol.2021.154838_bb0600) 2019; 6 Katzmarzyk (10.1016/j.metabol.2021.154838_bb0555) 2014; 46 (10.1016/j.metabol.2021.154838_bb0005) 2017 Echouffo-Tcheugui (10.1016/j.metabol.2021.154838_bb0300) 2021; 44 Booth (10.1016/j.metabol.2021.154838_bb0085) 2006; 29 Lawlor (10.1016/j.metabol.2021.154838_bb0220) 2008; 27 Davis (10.1016/j.metabol.2021.154838_bb0260) 2019; 42 Coorey (10.1016/j.metabol.2021.154838_bb0595) 2018; 25 McMurray (10.1016/j.metabol.2021.154838_bb0630) 2019; 381 Razavi Nematollahi (10.1016/j.metabol.2021.154838_bb0350) 2009; 58 Micha (10.1016/j.metabol.2021.154838_bb0045) 2017; 317 O’Keefe (10.1016/j.metabol.2021.154838_bb0545) 2014; 89 McGuire (10.1016/j.metabol.2021.154838_bb0130) 2021; 6 O’Connor (10.1016/j.metabol.2021.154838_bb0150) 2011; 34 Bayoumy (10.1016/j.metabol.2021.154838_bb0570) 2021 Salas-Salvadó (10.1016/j.metabol.2021.154838_bb0590) 2019; 42 Mellbin (10.1016/j.metabol.2021.154838_bb0325) 2013; 34 Marso (10.1016/j.metabol.2021.154838_bb0665) 2016; 375 Gerstein (10.1016/j.metabol.2021.154838_bb0240) 2013; 1 Standl (10.1016/j.metabol.2021.154838_bb0270) 2018; 41 Laakso (10.1016/j.metabol.2021.154838_bb0390) 2014; 10 Peikes (10.1016/j.metabol.2021.154838_bb0155) 2009; 301 Holman (10.1016/j.metabol.2021.154838_bb0675) 2017; 377 Hernandez (10.1016/j.metabol.2021.154838_bb0680) 2018; 392 Rivera (10.1016/j.metabol.2021.154838_bb0190) 2013; 14 Kirk (10.1016/j.metabol.2021.154838_bb0615) 2019; 33 Lee (10.1016/j.metabol.2021.154838_bb0310) 2016; 68 Moore (10.1016/j.metabol.2021.154838_bb0415) 2011; 145 Li (10.1016/j.metabol.2021.154838_bb0515) 2020; 43 van der Harst (10.1016/j.metabol.2021.154838_bb0200) 2018; 122 Cha (10.1016/j.metabol.2021.154838_bb0295) 2016; 40 Vergès (10.1016/j.metabol.2021.154838_bb0425) 2015; 58 Muniyappa (10.1016/j.metabol.2021.154838_bb0455) 2013; 14 Kamide (10.1016/j.metabol.2021.154838_bb0445) 2013; 9 Margulies (10.1016/j.metabol.2021.154838_bb0715) 2016; 316 Cannon (10.1016/j.metabol.2021.154838_bb0645) 2020; 383 Gerstein (10.1016/j.metabol.2021.154838_bb0685) 2019; 394 Gerstein (10.1016/j.metabol.2021.154838_bb0250) 2008; 358 Qasim (10.1016/j.metabol.2021.154838_bb0505) 2008; 52 Sommerfield (10.1016/j.metabol.2021.154838_bb0355) 2007; 293 Einarson (10.1016/j.metabol.2021.154838_bb0165) 2018; 17 Heller (10.1016/j.metabol.2021.154838_bb0330) 2017; 19 Amiel (10.1016/j.metabol.2021.154838_bb0360) 2021; 64 Singh (10.1016/j.metabol.2021.154838_bb0015) 2013; 8 Frier (10.1016/j.metabol.2021.154838_bb0265) 2011; 34 Rawshani (10.1016/j.metabol.2021.154838_bb0080) 2017; 376 Beck (10.1016/j.metabol.2021.154838_bb0145) 2017; 40 Ross (10.1016/j.metabol.2021.154838_bb0225) 2015; 36 Gast (10.1016/j.metabol.2021.154838_bb0485) 2012; 7 Seferović (10.1016/j.metabol.2021.154838_bb0725) 2020; 22 (10.1016/j.metabol.2021.154838_bb0140) 2021; 44 Pfeffer (10.1016/j.metabol.2021.154838_bb0660) 2015; 373 Rutter (10.1016/j.metabol.2021.154838_bb0475) 2005; 54 Ausk (10.1016/j.metabol.2021.154838_bb0480) 2010; 33 Guilherme (10.1016/j.metabol.2021.154838_bb0410) 2008; 9 Weintraub (10.1016/j.metabol.2021.154838_bb0565) 2011; 124 Kim (10.1016/j.metabol.2021.154838_bb0490) 2015; 70 Marso (10.1016/j.metabol.2021.154838_bb0670) 2016; 375 (10.1016/j.metabol.2021.154838_bb0285) 2019; 42 Rawshani (10.1016/j.metabol.2021.154838_bb0115) 2018; 379 Yun (10.1016/j.metabol.2021.154838_bb0320) 2019; 18 Pieber (10.1016/j.metabol.2021.154838_bb0335) 2018; 61 Gregg (10.1016/j.metabol.2021.154838_bb0030) 2012; 35 Shah (10.1016/j.metabol.2021.154838_bb0210) 2018; 41 Mahajan (10.1016/j.metabol.2021.154838_bb0195) 2018; 50 Jung (10.1016/j.metabol.2021.154838_bb0100) 2017; 16 Packer (10.1016/j.metabol.2021.154838_bb0650) 2020; 383 O’Donnell (10.1016/j.metabol.2021.154838_bb0560) 2016; 388 Simonson (10.1016/j.metabol.2021.154838_bb0185) 2011; 12 Zoungas (10.1016/j.metabol.2021.154838_bb0255) 2010; 363 Giugliano (10.1016/j.metabol.2021.154838_bb0055) 2021; 20 Robins (10.1016/j.metabol.2021.154838_bb0470) 2003; 26 Bornfeldt (10.1016/j.metabol.2021.154838_bb0420) 2011; 14 Fitzgibbons (10.1016/j.metabol.2021.154838_bb0400) 2014; 3 Després (10.1016/j.metabol.2021.154838_bb0525) 2011; 57 Yusuf (10.1016/j.metabol.2021.154838_bb0050) 2020; 395 Yun (10.1016/j.metabol.2021.154838_bb0215) 2021 Wiviott (10.1016/j.metabol.2021.154838_bb0640) 2019; 380 Kang (10.1016/j.metabol.2021.154838_bb0065) 2019; 43 Wright (10.1016/j.metabol.2021.154838_bb0120) 2020; 142 Ahmad (10.1016/j.metabol.2021.154838_bb0230) 2015; 6 Bonora (10.1016/j.metabol.2021.154838_bb0375) 2002; 25 Smith (10.1016/j.metabol.2021.154838_bb0605) 2020; 58 Inzucchi (10.1016/j.metabol.2021.154838_bb0280) 2012; 35 Gerstein (10.1016/j.metabol.2021.154838_bb0530) 2018; 20 Chapman (10.1016/j.metabol.2021.154838_bb0395) 2008; 117 Said (10.1016/j.metabol.2021.154838_bb0580) 2018; 3 Lorenz (10.1016/j.metabol.2021.154838_bb0720) 2017; 16 Han (10.1016/j.metabol.2021.154838_bb0370) 2018; 10 Zinman (10.1016/j.metabol.2021.154838_bb0620) 2015; 373 Merino (10.1016/j.metabol.2021.154838_bb0180) 2020; 69 Bonds (10.1016/j.metabol.2021.154838_bb0290) 2010; 340 Rashid (10.1016/j.metabol.2021.154838_bb0430) 2003; 36 Zinman (10.1016/j.metabol.2021.154838_bb0275) 2018; 41 Vakkilainen (10.1016/j.metabol.2021.154838_bb0435) 2003; 107 Stefan (10.1016/j.metabol.2021.154838_bb0405) 2020; 8 Yamazoe (10.1016/j.metabol.2021.154838_bb0495) 2016; 36 Park (10.1016/j.metabol.2021.154838_bb0105) 2021; 45 de Jager (10.1016/j.metabol.2021.154838_bb0460) 2006; 26 Rexrode (10.1016/j.metabol.2021.154838_bb0520) 1998; 280 |
References_xml | – volume: 10 start-page: 293 year: 2014 end-page: 302 ident: bb0390 article-title: Insulin resistance and hyperglycaemia in cardiovascular disease development publication-title: Nat Rev Endocrinol contributor: fullname: Kuusisto – volume: 64 start-page: 963 year: 2021 end-page: 970 ident: bb0360 article-title: The consequences of hypoglycaemia publication-title: Diabetologia. contributor: fullname: Amiel – year: 2017 ident: bb0005 publication-title: IDF diabetes atlas – volume: 8 start-page: 616 year: 2020 end-page: 627 ident: bb0405 article-title: Causes, consequences, and treatment of metabolically unhealthy fat distribution publication-title: Lancet Diabetes Endocrinol contributor: fullname: Stefan – volume: 64 start-page: 673 year: 2015 end-page: 686 ident: bb0535 article-title: Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes publication-title: Diabetes. contributor: fullname: Prentki – volume: 381 start-page: 841 year: 2019 end-page: 851 ident: bb0690 article-title: Oral Semaglutide and cardiovascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med contributor: fullname: Franco – volume: 40 start-page: 202 year: 2016 end-page: 210 ident: bb0295 article-title: Severe hypoglycemia and cardiovascular or all-cause mortality in patients with type 2 diabetes publication-title: Diabetes Metab J contributor: fullname: Song – volume: 316 start-page: 500 year: 2016 end-page: 508 ident: bb0715 article-title: Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial publication-title: Jama. contributor: fullname: Cole – volume: 117 start-page: 354 year: 2008 end-page: 373 ident: bb0395 article-title: Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy publication-title: Pharmacol Ther contributor: fullname: Sposito – volume: 33 start-page: 778 year: 2019 end-page: 791 ident: bb0615 article-title: Wearable technology and physical activity behavior change in adults with chronic cardiometabolic disease: a systematic review and meta-analysis publication-title: Am J Health Promot contributor: fullname: Ritvo – volume: 19 start-page: 35 year: 2020 ident: bb0695 article-title: Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney publication-title: Cardiovasc Diabetol contributor: fullname: Chiodini – volume: 69 start-page: 1116 year: 2017 end-page: 1125 ident: bb0040 article-title: Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population publication-title: J Am Coll Cardiol contributor: fullname: Chen – volume: 391 start-page: 2430 year: 2018 end-page: 2440 ident: bb0090 article-title: Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data publication-title: Lancet. contributor: fullname: Albright – volume: 36 start-page: 1454 year: 2015 end-page: 1462 ident: bb0225 article-title: Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease publication-title: Eur Heart J contributor: fullname: Paré – volume: 47 start-page: 254 year: 1982 end-page: 258 ident: bb0345 article-title: Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects publication-title: Thromb Haemost contributor: fullname: Hilsted – volume: 89 start-page: 382 year: 2014 end-page: 393 ident: bb0545 article-title: Alcohol and cardiovascular health: the dose makes the poison…or the remedy publication-title: Mayo Clin Proc contributor: fullname: Lavie – volume: 377 start-page: 1228 year: 2017 end-page: 1239 ident: bb0675 article-title: Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Buse – volume: 368 start-page: 1651 year: 2006 end-page: 1659 ident: bb0020 article-title: Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment publication-title: Lancet. contributor: fullname: Ezzati – volume: 72 start-page: 1763 year: 2018 end-page: 1773 ident: bb0705 article-title: Genetic variants in SGLT1, glucose tolerance, and cardiometabolic risk publication-title: J Am Coll Cardiol contributor: fullname: Kuokkanen – volume: 41 start-page: 348 year: 2018 end-page: 355 ident: bb0210 article-title: Modulation of GLP-1 levels by a genetic variant that regulates the cardiovascular effects of intensive glycemic control in ACCORD publication-title: Diabetes Care contributor: fullname: Wagner – volume: 122 start-page: 433 year: 2018 end-page: 443 ident: bb0200 article-title: Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease publication-title: Circ Res contributor: fullname: Verweij – volume: 34 start-page: S132 year: 2011 end-page: S137 ident: bb0265 article-title: Hypoglycemia and cardiovascular risks publication-title: Diabetes Care contributor: fullname: Heller – volume: 107 start-page: 1733 year: 2003 end-page: 1737 ident: bb0435 article-title: Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS) publication-title: Circulation. contributor: fullname: Foucher – volume: 1 start-page: 71 year: 2013 end-page: 78 ident: bb0240 article-title: Dysglycaemia, vasculopenia, and the chronic consequences of diabetes publication-title: Lancet Diabetes Endocrinol contributor: fullname: Werstuck – volume: 58 start-page: 886 year: 2015 end-page: 899 ident: bb0425 article-title: Pathophysiology of diabetic dyslipidaemia: where are we? publication-title: Diabetologia. contributor: fullname: Vergès – volume: 371 start-page: 1783 year: 2008 end-page: 1789 ident: bb0585 article-title: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study publication-title: Lancet. contributor: fullname: Gong – volume: 45 start-page: 120 year: 2021 end-page: 124 ident: bb0105 article-title: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea publication-title: Diabetes Metab J contributor: fullname: Kim – volume: 44 start-page: 248 year: 2021 end-page: 254 ident: bb0300 article-title: Severe hypoglycemia, cardiac structure and function, and risk of cardiovascular events among older adults with diabetes publication-title: Diabetes Care contributor: fullname: Windham – volume: 33 start-page: 1179 year: 2010 end-page: 1185 ident: bb0480 article-title: Insulin resistance predicts mortality in nondiabetic individuals in the U.S. publication-title: Diabetes Care contributor: fullname: Ioannou – volume: 26 start-page: 1086 year: 2006 end-page: 1093 ident: bb0460 article-title: Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Heine – volume: 375 start-page: 2349 year: 2016 end-page: 2358 ident: bb0575 article-title: Genetic risk, adherence to a healthy lifestyle, and coronary disease publication-title: N Engl J Med contributor: fullname: Cook – volume: 142 start-page: 1925 year: 2020 end-page: 1936 ident: bb0120 article-title: Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings publication-title: Circulation. contributor: fullname: Emsley – volume: 12 start-page: 146 year: 2011 ident: bb0185 article-title: Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease risk publication-title: BMC Med Genet contributor: fullname: McQueen – volume: 41 start-page: 917 year: 2018 end-page: 928 ident: bb0010 article-title: Economic costs of diabetes in the U.S. in 2017 publication-title: Diabetes Care – volume: 9 start-page: 238 year: 2013 end-page: 245 ident: bb0445 article-title: Role of renin-angiotensin-aldosterone system in metabolic syndrome and obesity-related hypertension publication-title: Curr Hypertens Rev contributor: fullname: Kamide – volume: 56 start-page: 2601 year: 2013 end-page: 2608 ident: bb0095 article-title: Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study publication-title: Diabetologia. contributor: fullname: Ekeroth – volume: 33 start-page: 1389 year: 2010 end-page: 1394 ident: bb0340 article-title: Hypoglycemia, diabetes, and cardiovascular events publication-title: Diabetes Care contributor: fullname: Fonseca – volume: 41 start-page: 3346 year: 2020 end-page: 3358 ident: bb0060 article-title: Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials publication-title: Eur Heart J contributor: fullname: Esposito – volume: 43 start-page: 410 year: 2019 end-page: 421 ident: bb0065 article-title: Asian subpopulations may exhibit greater cardiovascular benefit from long-acting glucagon-like peptide 1 receptor agonists: a meta-analysis of cardiovascular outcome trials publication-title: Diabetes Metab J contributor: fullname: Park – volume: 8 year: 2013 ident: bb0500 article-title: Relationship between insulin resistance and coronary artery calcium in young men and women publication-title: PLoS One contributor: fullname: Kwag – volume: 36 start-page: 421 year: 2003 end-page: 429 ident: bb0430 article-title: Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity publication-title: Clin Biochem contributor: fullname: Lewis – volume: 25 start-page: 505 year: 2018 end-page: 521 ident: bb0595 article-title: Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: systematic review with meta-synthesis of quantitative and qualitative data publication-title: Eur J Prev Cardiol contributor: fullname: Redfern – volume: 36 start-page: 1703 year: 2016 end-page: 1708 ident: bb0495 article-title: Relationship of insulin resistance to prevalence and progression of coronary artery calcification beyond metabolic syndrome components: Shiga epidemiological study of subclinical atherosclerosis publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Kadota – volume: 363 start-page: 1410 year: 2010 end-page: 1418 ident: bb0255 article-title: Severe hypoglycemia and risks of vascular events and death publication-title: N Engl J Med contributor: fullname: Billot – volume: 380 start-page: 347 year: 2019 end-page: 357 ident: bb0640 article-title: Dapagliflozin and cardiovascular outcomes in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Cahn – volume: 17 start-page: 330 year: 2012 end-page: 341 ident: bb0440 article-title: Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease publication-title: Vasc Med contributor: fullname: Zeng – volume: 42 start-page: 157 year: 2019 end-page: 163 ident: bb0260 article-title: Effects of severe hypoglycemia on cardiovascular outcomes and death in the veterans affairs diabetes trial publication-title: Diabetes Care contributor: fullname: Thottapurathu – volume: 381 start-page: 1995 year: 2019 end-page: 2008 ident: bb0630 article-title: Dapagliflozin in patients with heart failure and reduced ejection fraction publication-title: N Engl J Med contributor: fullname: Martinez – volume: 69 start-page: 112 year: 2020 end-page: 120 ident: bb0180 article-title: Interaction between type 2 diabetes prevention strategies and genetic determinants of coronary artery disease on cardiometabolic risk factors publication-title: Diabetes. contributor: fullname: Harden – volume: 375 start-page: 311 year: 2016 end-page: 322 ident: bb0670 article-title: Liraglutide and cardiovascular outcomes in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Nauck – volume: 28 start-page: 527 year: 2010 end-page: 535 ident: bb0450 article-title: Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation publication-title: J Hypertens contributor: fullname: Raij – volume: 34 start-page: 1651 year: 2011 end-page: 1659 ident: bb0150 article-title: Diabetes performance measures: current status and future directions publication-title: Diabetes Care contributor: fullname: Gregg – volume: 119 start-page: 1728 year: 2009 end-page: 1735 ident: bb0025 article-title: Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005 publication-title: Circulation. contributor: fullname: Savage – volume: 376 start-page: 1407 year: 2017 end-page: 1418 ident: bb0080 article-title: Mortality and cardiovascular disease in type 1 and type 2 diabetes publication-title: N Engl J Med contributor: fullname: Miftaraj – volume: 20 start-page: 564 year: 2018 end-page: 570 ident: bb0530 article-title: Insulin resistance and cardiovascular outcomes in the ORIGIN trial publication-title: Diabetes Obes Metab contributor: fullname: Yusuf – volume: 43 start-page: 1929 year: 2020 end-page: 1936 ident: bb0515 article-title: Individual and combined associations of modifiable lifestyle and metabolic health status with new-onset diabetes and major cardiovascular events: the China Cardiometabolic Disease and Cancer Cohort (4C) study publication-title: Diabetes Care contributor: fullname: Zhao – volume: 68 start-page: 1370 year: 2016 end-page: 1371 ident: bb0310 article-title: Severe hypoglycemia and elevated high-sensitivity cardiac troponin T in older adults with diabetes: the ARIC study publication-title: J Am Coll Cardiol contributor: fullname: Selvin – volume: 44 start-page: S73 year: 2021 end-page: s84 ident: bb0365 article-title: 6. Glycemic targets: standards of medical care in diabetes-2021 publication-title: Diabetes Care – volume: 29 start-page: 329 year: 2006 end-page: 333 ident: bb0465 article-title: High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study publication-title: Diabetes Care contributor: fullname: Rönnemaa – volume: 40 start-page: 687 year: 2017 end-page: 693 ident: bb0235 article-title: Genetically driven hyperglycemia increases risk of coronary artery disease separately from type 2 diabetes publication-title: Diabetes Care contributor: fullname: Dupuis – start-page: 1 year: 2021 end-page: 19 ident: bb0570 article-title: Smart wearable devices in cardiovascular care: where we are and how to move forward publication-title: Nat Rev Cardiol contributor: fullname: Marvel – volume: 58 start-page: 443 year: 2009 end-page: 448 ident: bb0350 article-title: Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects publication-title: Metabolism. contributor: fullname: Tehrani – volume: 18 start-page: 20 year: 2019 ident: bb0700 article-title: Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives publication-title: Cardiovasc Diabetol contributor: fullname: Mezza – volume: 40 start-page: 468 year: 2017 end-page: 475 ident: bb0125 article-title: Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013 publication-title: Diabetes Care contributor: fullname: Steinman – volume: 43 start-page: 487 year: 2020 end-page: 493 ident: bb0730 article-title: 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) publication-title: Diabetes Care contributor: fullname: Mathieu – volume: 34 start-page: 3137 year: 2013 end-page: 3144 ident: bb0325 article-title: Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial publication-title: Eur Heart J contributor: fullname: Díaz – volume: 280 start-page: 1843 year: 1998 end-page: 1848 ident: bb0520 article-title: Abdominal adiposity and coronary heart disease in women publication-title: Jama. contributor: fullname: Stampfer – volume: 383 start-page: 1425 year: 2020 end-page: 1435 ident: bb0645 article-title: Cardiovascular outcomes with Ertugliflozin in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Masiukiewicz – volume: 27 start-page: 1133 year: 2008 end-page: 1163 ident: bb0220 article-title: Mendelian randomization: using genes as instruments for making causal inferences in epidemiology publication-title: Stat Med contributor: fullname: Davey – volume: 42 start-page: 777 year: 2019 end-page: 788 ident: bb0590 article-title: Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial publication-title: Diabetes Care contributor: fullname: Corella – volume: 50 start-page: 1505 year: 2018 end-page: 1513 ident: bb0195 article-title: Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps publication-title: Nat Genet contributor: fullname: Rayner – volume: 394 start-page: 121 year: 2019 end-page: 130 ident: bb0685 article-title: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial publication-title: Lancet. contributor: fullname: Pais – volume: 14 start-page: 5 year: 2013 end-page: 12 ident: bb0455 article-title: Role of insulin resistance in endothelial dysfunction publication-title: Rev Endocr Metab Disord contributor: fullname: Sowers – volume: 17 start-page: 83 year: 2018 ident: bb0165 article-title: Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017 publication-title: Cardiovasc Diabetol contributor: fullname: Panton – volume: 124 start-page: 967 year: 2011 end-page: 990 ident: bb0565 article-title: Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association publication-title: Circulation. contributor: fullname: Hayman – volume: 6 year: 2019 ident: bb0600 article-title: Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis publication-title: Open Heart contributor: fullname: Pfaeffli Dale – volume: 388 start-page: 761 year: 2016 end-page: 775 ident: bb0560 article-title: Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study publication-title: Lancet. contributor: fullname: Zhang – volume: 8 year: 2013 ident: bb0015 article-title: The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis publication-title: PLoS One contributor: fullname: Wormser – volume: 44 start-page: S40 year: 2021 end-page: s52 ident: bb0140 article-title: 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2021 publication-title: Diabetes Care – volume: 317 start-page: 912 year: 2017 end-page: 924 ident: bb0045 article-title: Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States publication-title: Jama. contributor: fullname: Mozaffarian – volume: 360 start-page: 129 year: 2009 end-page: 139 ident: bb0245 article-title: Glucose control and vascular complications in veterans with type 2 diabetes publication-title: N Engl J Med contributor: fullname: Reaven – volume: 301 start-page: 603 year: 2009 end-page: 618 ident: bb0155 article-title: Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials publication-title: Jama. contributor: fullname: Brown – volume: 9 start-page: 367 year: 2008 end-page: 377 ident: bb0410 article-title: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes publication-title: Nat Rev Mol Cell Biol contributor: fullname: Czech – volume: 5 year: 2016 ident: bb0305 article-title: Association between severe hypoglycemia and cardiovascular disease risk in Japanese patients with type 2 diabetes publication-title: J Am Heart Assoc contributor: fullname: Noda – volume: 54 start-page: 3252 year: 2005 end-page: 3257 ident: bb0475 article-title: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study publication-title: Diabetes. contributor: fullname: Wilson – volume: 358 start-page: 580 year: 2008 end-page: 591 ident: bb0135 article-title: Effect of a multifactorial intervention on mortality in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Pedersen – volume: 317 start-page: 280 year: 2017 end-page: 289 ident: bb0170 article-title: Association between diabetes and cause-specific mortality in rural and urban areas of China publication-title: Jama. contributor: fullname: Chen – volume: 49 start-page: 1392 year: 2017 end-page: 1397 ident: bb0205 article-title: Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease publication-title: Nat Genet contributor: fullname: McMillan – volume: 3 start-page: 693 year: 2018 end-page: 702 ident: bb0580 article-title: Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study publication-title: JAMA Cardiol contributor: fullname: van der Harst – volume: 377 start-page: 644 year: 2017 end-page: 657 ident: bb0625 article-title: Canagliflozin and cardiovascular and renal events in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Erondu – volume: 14 start-page: 575 year: 2011 end-page: 585 ident: bb0420 article-title: Insulin resistance, hyperglycemia, and atherosclerosis publication-title: Cell Metab contributor: fullname: Tabas – volume: 61 start-page: 58 year: 2018 end-page: 65 ident: bb0335 article-title: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality publication-title: Diabetologia. contributor: fullname: Emerson – volume: 20 start-page: 17 year: 2021 ident: bb0055 article-title: Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes publication-title: Cardiovasc Diabetol contributor: fullname: Esposito – volume: 26 start-page: 1513 year: 2003 end-page: 1517 ident: bb0470 article-title: Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT) publication-title: Diabetes Care contributor: fullname: Anderson – volume: 58 start-page: 142 year: 2020 end-page: 151 ident: bb0605 article-title: Text message interventions for physical activity: a systematic review and meta-analysis publication-title: Am J Prev Med contributor: fullname: Celano – volume: 25 start-page: 1177 year: 2002 end-page: 1184 ident: bb0380 article-title: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study publication-title: Diabetes Care contributor: fullname: Haffner – volume: 392 start-page: 1519 year: 2018 end-page: 1529 ident: bb0680 article-title: Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial publication-title: Lancet. contributor: fullname: Jones – volume: 22 start-page: 196 year: 2020 end-page: 213 ident: bb0725 article-title: European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure publication-title: Eur J Heart Fail contributor: fullname: Jhund – volume: 11 start-page: 895 year: 2003 end-page: 903 ident: bb0510 article-title: Waist circumference, BMI, smoking, and mortality in middle-aged men and women publication-title: Obes Res contributor: fullname: Sørensen – volume: 52 start-page: 231 year: 2008 end-page: 236 ident: bb0505 article-title: Adipokines, insulin resistance, and coronary artery calcification publication-title: J Am Coll Cardiol contributor: fullname: Girman – volume: 40 start-page: 1409 year: 2017 end-page: 1419 ident: bb0145 article-title: 2017 national standards for diabetes self-management education and support publication-title: Diabetes Care contributor: fullname: Condon – volume: 358 start-page: 2545 year: 2008 end-page: 2559 ident: bb0250 article-title: Effects of intensive glucose lowering in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Buse – volume: 293 start-page: E1274 year: 2007 end-page: E1279 ident: bb0355 article-title: Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia publication-title: Am J Physiol Endocrinol Metab contributor: fullname: Frier – volume: 373 start-page: 2117 year: 2015 end-page: 2128 ident: bb0620 article-title: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes publication-title: N Engl J Med contributor: fullname: Hantel – volume: 383 start-page: 1413 year: 2020 end-page: 1424 ident: bb0650 article-title: Cardiovascular and renal outcomes with Empagliflozin in heart failure publication-title: N Engl J Med contributor: fullname: Carson – year: 2021 ident: bb0215 article-title: Polygenic risk, lifestyle, and cardiovascular mortality: a prospective population-based UK Biobank study publication-title: medRxiv contributor: fullname: Park – volume: 7 year: 2012 ident: bb0485 article-title: Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis publication-title: PLoS One contributor: fullname: Dekkers – volume: 7 year: 2019 ident: bb0610 article-title: Consumer-based wearable activity trackers increase physical activity participation: systematic review and meta-analysis publication-title: JMIR Mhealth Uhealth contributor: fullname: Williams – volume: 29 start-page: 32 year: 2006 end-page: 37 ident: bb0085 article-title: Recent trends in cardiovascular complications among men and women with and without diabetes publication-title: Diabetes Care contributor: fullname: Tu – volume: 3 year: 2014 ident: bb0400 article-title: Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations publication-title: J Am Heart Assoc contributor: fullname: Czech – volume: 6 start-page: 7060 year: 2015 ident: bb0230 article-title: A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease publication-title: Nat Commun contributor: fullname: Li – volume: 19 start-page: 664 year: 2017 end-page: 671 ident: bb0330 article-title: Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial publication-title: Diabetes Obes Metab contributor: fullname: Cushman – volume: 14 start-page: 11 year: 2013 ident: bb0190 article-title: Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes publication-title: BMC Med Genet contributor: fullname: Mezzelani – volume: 46 start-page: 940 year: 2014 end-page: 946 ident: bb0555 article-title: Standing and mortality in a prospective cohort of Canadian adults publication-title: Med Sci Sports Exerc contributor: fullname: Katzmarzyk – volume: 373 start-page: 2247 year: 2015 end-page: 2257 ident: bb0660 article-title: Lixisenatide in patients with type 2 diabetes and acute coronary syndrome publication-title: N Engl J Med contributor: fullname: Køber – volume: 41 start-page: 2306 year: 2018 end-page: 2315 ident: bb0110 article-title: Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes, 1988-2015 publication-title: Diabetes Care contributor: fullname: Ali – volume: 18 start-page: 103 year: 2019 ident: bb0320 article-title: Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study publication-title: Cardiovasc Diabetol contributor: fullname: Ko – volume: 41 start-page: 596 year: 2018 end-page: 603 ident: bb0270 article-title: Increased risk of severe hypoglycemic events before and after cardiovascular outcomes in TECOS suggests an at-risk type 2 diabetes frail patient phenotype publication-title: Diabetes Care contributor: fullname: Green – volume: 70 start-page: 847 year: 2015 end-page: 853 ident: bb0490 article-title: Paradoxical associations of insulin resistance with total and cardiovascular mortality in humans publication-title: J Gerontol A Biol Sci Med Sci contributor: fullname: Lee – volume: 384 start-page: 129 year: 2021 end-page: 139 ident: bb0655 article-title: Sotagliflozin in patients with diabetes and chronic kidney disease publication-title: N Engl J Med contributor: fullname: McGuire – volume: 340 start-page: b4909 year: 2010 ident: bb0290 article-title: The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study publication-title: Bmj. contributor: fullname: Cutler – volume: 42 start-page: S61 year: 2019 end-page: s70 ident: bb0285 article-title: 6. Glycemic targets: standards of medical care in diabetes-2019 publication-title: Diabetes Care – volume: 41 start-page: 1783 year: 2018 end-page: 1791 ident: bb0275 article-title: Hypoglycemia, cardiovascular outcomes, and death: the LEADER experience publication-title: Diabetes Care contributor: fullname: Buse – volume: 30 start-page: 318 year: 2007 end-page: 324 ident: bb0385 article-title: Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study publication-title: Diabetes Care contributor: fullname: Meigs – volume: 380 start-page: 2295 year: 2019 end-page: 2306 ident: bb0635 article-title: Canagliflozin and renal outcomes in type 2 diabetes and nephropathy publication-title: N Engl J Med contributor: fullname: Charytan – volume: 64 start-page: 472 year: 2014 end-page: 481 ident: bb0550 article-title: Leisure-time running reduces all-cause and cardiovascular mortality risk publication-title: J Am Coll Cardiol contributor: fullname: Blair – volume: 10 start-page: 1545 year: 2018 end-page: 1559 ident: bb0370 article-title: Development and validation of a risk prediction model for severe hypoglycemia in adult patients with type 2 diabetes: a nationwide population-based cohort study publication-title: Clin Epidemiol contributor: fullname: Cha – volume: 370 start-page: 1514 year: 2014 end-page: 1523 ident: bb0075 article-title: Changes in diabetes-related complications in the United States, 1990-2010 publication-title: N Engl J Med contributor: fullname: Rolka – volume: 395 start-page: 795 year: 2020 end-page: 808 ident: bb0050 article-title: Modifiable risk factors, cardiovascular disease, and mortality in 155 publication-title: Lancet. contributor: fullname: Hystad – volume: 6 start-page: 148 year: 2021 end-page: 158 ident: bb0130 article-title: Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis publication-title: JAMA Cardiol contributor: fullname: Dagogo-Jack – volume: 35 start-page: 1364 year: 2012 end-page: 1379 ident: bb0280 article-title: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) publication-title: Diabetes Care contributor: fullname: Nauck – volume: 145 start-page: 341 year: 2011 end-page: 355 ident: bb0415 article-title: Macrophages in the pathogenesis of atherosclerosis publication-title: Cell. contributor: fullname: Tabas – volume: 16 start-page: 1 year: 2017 ident: bb0100 article-title: Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013) publication-title: Cardiovasc Diabetol contributor: fullname: Park – volume: 379 start-page: 2252 year: 2012 end-page: 2261 ident: bb0160 article-title: Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis publication-title: Lancet. contributor: fullname: Galipeau – volume: 57 start-page: 1887 year: 2011 end-page: 1889 ident: bb0525 article-title: Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? publication-title: J Am Coll Cardiol contributor: fullname: Després – volume: 71 start-page: 2867 year: 2018 end-page: 2876 ident: bb0035 article-title: Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus publication-title: J Am Coll Cardiol contributor: fullname: Rimm – volume: 35 start-page: 1252 year: 2012 end-page: 1257 ident: bb0030 article-title: Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey publication-title: Diabetes Care contributor: fullname: Geiss – volume: 25 start-page: 1135 year: 2002 end-page: 1141 ident: bb0375 article-title: HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study publication-title: Diabetes Care contributor: fullname: Zenari – volume: 375 start-page: 1834 year: 2016 end-page: 1844 ident: bb0665 article-title: Semaglutide and cardiovascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med contributor: fullname: Leiter – volume: 41 start-page: 104 year: 2018 end-page: 111 ident: bb0315 article-title: The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes publication-title: Diabetes Care contributor: fullname: Huang – volume: 379 start-page: 633 year: 2018 end-page: 644 ident: bb0115 article-title: Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med contributor: fullname: Svensson – volume: 16 start-page: 6 year: 2017 ident: bb0720 article-title: Differential effects of glucagon-like peptide-1 receptor agonists on heart rate publication-title: Cardiovasc Diabetol contributor: fullname: Lehmann – volume: 132 start-page: 997 year: 2015 end-page: 1002 ident: bb0175 article-title: Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women publication-title: Circulation contributor: fullname: Vaccarino – volume: 34 start-page: 509 year: 2014 end-page: 515 ident: bb0540 article-title: Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Bernhard – volume: 118 start-page: 1723 year: 2016 end-page: 1735 ident: bb0070 article-title: Epidemiology of obesity and diabetes and their cardiovascular complications publication-title: Circ Res contributor: fullname: Hu – volume: 19 start-page: 69 year: 2017 end-page: 77 ident: bb0710 article-title: Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial publication-title: Eur J Heart Fail contributor: fullname: Hänselmann – volume: 20 start-page: 17 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0055 article-title: Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-021-01213-w contributor: fullname: Giugliano – volume: 7 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0610 article-title: Consumer-based wearable activity trackers increase physical activity participation: systematic review and meta-analysis publication-title: JMIR Mhealth Uhealth doi: 10.2196/11819 contributor: fullname: Brickwood – volume: 14 start-page: 575 year: 2011 ident: 10.1016/j.metabol.2021.154838_bb0420 article-title: Insulin resistance, hyperglycemia, and atherosclerosis publication-title: Cell Metab doi: 10.1016/j.cmet.2011.07.015 contributor: fullname: Bornfeldt – volume: 43 start-page: 487 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0730 article-title: 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) publication-title: Diabetes Care doi: 10.2337/dci19-0066 contributor: fullname: Buse – volume: 10 start-page: 293 year: 2014 ident: 10.1016/j.metabol.2021.154838_bb0390 article-title: Insulin resistance and hyperglycaemia in cardiovascular disease development publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2014.29 contributor: fullname: Laakso – volume: 1 start-page: 71 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0240 article-title: Dysglycaemia, vasculopenia, and the chronic consequences of diabetes publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(13)70025-1 contributor: fullname: Gerstein – volume: 20 start-page: 564 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0530 article-title: Insulin resistance and cardiovascular outcomes in the ORIGIN trial publication-title: Diabetes Obes Metab doi: 10.1111/dom.13112 contributor: fullname: Gerstein – volume: 8 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0500 article-title: Relationship between insulin resistance and coronary artery calcium in young men and women publication-title: PLoS One doi: 10.1371/journal.pone.0053316 contributor: fullname: Sung – volume: 317 start-page: 912 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0045 article-title: Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States publication-title: Jama. doi: 10.1001/jama.2017.0947 contributor: fullname: Micha – volume: 380 start-page: 2295 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0635 article-title: Canagliflozin and renal outcomes in type 2 diabetes and nephropathy publication-title: N Engl J Med doi: 10.1056/NEJMoa1811744 contributor: fullname: Perkovic – volume: 58 start-page: 142 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0605 article-title: Text message interventions for physical activity: a systematic review and meta-analysis publication-title: Am J Prev Med doi: 10.1016/j.amepre.2019.08.014 contributor: fullname: Smith – volume: 301 start-page: 603 year: 2009 ident: 10.1016/j.metabol.2021.154838_bb0155 article-title: Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials publication-title: Jama. doi: 10.1001/jama.2009.126 contributor: fullname: Peikes – volume: 17 start-page: 83 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0165 article-title: Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-018-0728-6 contributor: fullname: Einarson – volume: 119 start-page: 1728 year: 2009 ident: 10.1016/j.metabol.2021.154838_bb0025 article-title: Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005 publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.108.829176 contributor: fullname: Preis – volume: 36 start-page: 1454 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0225 article-title: Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv083 contributor: fullname: Ross – volume: 340 start-page: b4909 year: 2010 ident: 10.1016/j.metabol.2021.154838_bb0290 article-title: The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study publication-title: Bmj. doi: 10.1136/bmj.b4909 contributor: fullname: Bonds – volume: 370 start-page: 1514 year: 2014 ident: 10.1016/j.metabol.2021.154838_bb0075 article-title: Changes in diabetes-related complications in the United States, 1990-2010 publication-title: N Engl J Med doi: 10.1056/NEJMoa1310799 contributor: fullname: Gregg – volume: 30 start-page: 318 year: 2007 ident: 10.1016/j.metabol.2021.154838_bb0385 article-title: Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study publication-title: Diabetes Care doi: 10.2337/dc06-0919 contributor: fullname: Bonora – volume: 117 start-page: 354 year: 2008 ident: 10.1016/j.metabol.2021.154838_bb0395 article-title: Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2007.10.004 contributor: fullname: Chapman – volume: 35 start-page: 1364 year: 2012 ident: 10.1016/j.metabol.2021.154838_bb0280 article-title: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) publication-title: Diabetes Care doi: 10.2337/dc12-0413 contributor: fullname: Inzucchi – volume: 3 year: 2014 ident: 10.1016/j.metabol.2021.154838_bb0400 article-title: Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations publication-title: J Am Heart Assoc doi: 10.1161/JAHA.113.000582 contributor: fullname: Fitzgibbons – volume: 16 start-page: 6 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0720 article-title: Differential effects of glucagon-like peptide-1 receptor agonists on heart rate publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-016-0490-6 contributor: fullname: Lorenz – volume: 57 start-page: 1887 year: 2011 ident: 10.1016/j.metabol.2021.154838_bb0525 article-title: Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.10.063 contributor: fullname: Després – year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0005 – volume: 379 start-page: 2252 year: 2012 ident: 10.1016/j.metabol.2021.154838_bb0160 article-title: Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis publication-title: Lancet. doi: 10.1016/S0140-6736(12)60480-2 contributor: fullname: Tricco – volume: 25 start-page: 1177 year: 2002 ident: 10.1016/j.metabol.2021.154838_bb0380 article-title: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study publication-title: Diabetes Care doi: 10.2337/diacare.25.7.1177 contributor: fullname: Hanley – volume: 41 start-page: 1783 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0275 article-title: Hypoglycemia, cardiovascular outcomes, and death: the LEADER experience publication-title: Diabetes Care doi: 10.2337/dc17-2677 contributor: fullname: Zinman – volume: 40 start-page: 202 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0295 article-title: Severe hypoglycemia and cardiovascular or all-cause mortality in patients with type 2 diabetes publication-title: Diabetes Metab J doi: 10.4093/dmj.2016.40.3.202 contributor: fullname: Cha – volume: 360 start-page: 129 year: 2009 ident: 10.1016/j.metabol.2021.154838_bb0245 article-title: Glucose control and vascular complications in veterans with type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa0808431 contributor: fullname: Duckworth – volume: 58 start-page: 886 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0425 article-title: Pathophysiology of diabetic dyslipidaemia: where are we? publication-title: Diabetologia. doi: 10.1007/s00125-015-3525-8 contributor: fullname: Vergès – volume: 47 start-page: 254 year: 1982 ident: 10.1016/j.metabol.2021.154838_bb0345 article-title: Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects publication-title: Thromb Haemost doi: 10.1055/s-0038-1657180 contributor: fullname: Dalsgaard-Nielsen – volume: 44 start-page: S40 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0140 article-title: 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2021 publication-title: Diabetes Care doi: 10.2337/dc21-S004 – volume: 358 start-page: 2545 year: 2008 ident: 10.1016/j.metabol.2021.154838_bb0250 article-title: Effects of intensive glucose lowering in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa0802743 contributor: fullname: Gerstein – volume: 29 start-page: 32 year: 2006 ident: 10.1016/j.metabol.2021.154838_bb0085 article-title: Recent trends in cardiovascular complications among men and women with and without diabetes publication-title: Diabetes Care doi: 10.2337/diacare.29.01.06.dc05-0776 contributor: fullname: Booth – volume: 33 start-page: 778 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0615 article-title: Wearable technology and physical activity behavior change in adults with chronic cardiometabolic disease: a systematic review and meta-analysis publication-title: Am J Health Promot doi: 10.1177/0890117118816278 contributor: fullname: Kirk – volume: 42 start-page: 157 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0260 article-title: Effects of severe hypoglycemia on cardiovascular outcomes and death in the veterans affairs diabetes trial publication-title: Diabetes Care doi: 10.2337/dc18-1144 contributor: fullname: Davis – volume: 107 start-page: 1733 year: 2003 ident: 10.1016/j.metabol.2021.154838_bb0435 article-title: Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS) publication-title: Circulation. doi: 10.1161/01.CIR.0000057982.50167.6E contributor: fullname: Vakkilainen – year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0215 article-title: Polygenic risk, lifestyle, and cardiovascular mortality: a prospective population-based UK Biobank study publication-title: medRxiv contributor: fullname: Yun – volume: 383 start-page: 1413 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0650 article-title: Cardiovascular and renal outcomes with Empagliflozin in heart failure publication-title: N Engl J Med doi: 10.1056/NEJMoa2022190 contributor: fullname: Packer – volume: 41 start-page: 596 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0270 article-title: Increased risk of severe hypoglycemic events before and after cardiovascular outcomes in TECOS suggests an at-risk type 2 diabetes frail patient phenotype publication-title: Diabetes Care doi: 10.2337/dc17-1778 contributor: fullname: Standl – volume: 14 start-page: 5 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0455 article-title: Role of insulin resistance in endothelial dysfunction publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-012-9229-1 contributor: fullname: Muniyappa – volume: 34 start-page: S132 issue: Suppl. 2 year: 2011 ident: 10.1016/j.metabol.2021.154838_bb0265 article-title: Hypoglycemia and cardiovascular risks publication-title: Diabetes Care doi: 10.2337/dc11-s220 contributor: fullname: Frier – volume: 392 start-page: 1519 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0680 article-title: Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial publication-title: Lancet. doi: 10.1016/S0140-6736(18)32261-X contributor: fullname: Hernandez – volume: 25 start-page: 505 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0595 article-title: Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: systematic review with meta-synthesis of quantitative and qualitative data publication-title: Eur J Prev Cardiol doi: 10.1177/2047487317750913 contributor: fullname: Coorey – volume: 12 start-page: 146 year: 2011 ident: 10.1016/j.metabol.2021.154838_bb0185 article-title: Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease risk publication-title: BMC Med Genet doi: 10.1186/1471-2350-12-146 contributor: fullname: Simonson – volume: 18 start-page: 20 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0700 article-title: Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-019-0828-y contributor: fullname: Cefalo – volume: 19 start-page: 664 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0330 article-title: Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial publication-title: Diabetes Obes Metab doi: 10.1111/dom.12871 contributor: fullname: Heller – volume: 41 start-page: 3346 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0060 article-title: Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa082 contributor: fullname: Marsico – volume: 7 year: 2012 ident: 10.1016/j.metabol.2021.154838_bb0485 article-title: Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0052036 contributor: fullname: Gast – volume: 375 start-page: 2349 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0575 article-title: Genetic risk, adherence to a healthy lifestyle, and coronary disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1605086 contributor: fullname: Khera – volume: 9 start-page: 367 year: 2008 ident: 10.1016/j.metabol.2021.154838_bb0410 article-title: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2391 contributor: fullname: Guilherme – volume: 64 start-page: 963 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0360 article-title: The consequences of hypoglycaemia publication-title: Diabetologia. doi: 10.1007/s00125-020-05366-3 contributor: fullname: Amiel – volume: 46 start-page: 940 year: 2014 ident: 10.1016/j.metabol.2021.154838_bb0555 article-title: Standing and mortality in a prospective cohort of Canadian adults publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0000000000000198 contributor: fullname: Katzmarzyk – volume: 371 start-page: 1783 year: 2008 ident: 10.1016/j.metabol.2021.154838_bb0585 article-title: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study publication-title: Lancet. doi: 10.1016/S0140-6736(08)60766-7 contributor: fullname: Li – volume: 373 start-page: 2117 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0620 article-title: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1504720 contributor: fullname: Zinman – volume: 44 start-page: S73 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0365 article-title: 6. Glycemic targets: standards of medical care in diabetes-2021 publication-title: Diabetes Care doi: 10.2337/dc21-S006 – volume: 19 start-page: 35 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0695 article-title: Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01010-x contributor: fullname: Giugliano – volume: 118 start-page: 1723 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0070 article-title: Epidemiology of obesity and diabetes and their cardiovascular complications publication-title: Circ Res doi: 10.1161/CIRCRESAHA.115.306825 contributor: fullname: Bhupathiraju – volume: 41 start-page: 104 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0315 article-title: The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc17-1669 contributor: fullname: Lee – volume: 375 start-page: 1834 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0665 article-title: Semaglutide and cardiovascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1607141 contributor: fullname: Marso – volume: 363 start-page: 1410 year: 2010 ident: 10.1016/j.metabol.2021.154838_bb0255 article-title: Severe hypoglycemia and risks of vascular events and death publication-title: N Engl J Med doi: 10.1056/NEJMoa1003795 contributor: fullname: Zoungas – volume: 69 start-page: 1116 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0040 article-title: Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.11.076 contributor: fullname: Lv – volume: 35 start-page: 1252 year: 2012 ident: 10.1016/j.metabol.2021.154838_bb0030 article-title: Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey publication-title: Diabetes Care doi: 10.2337/dc11-1162 contributor: fullname: Gregg – volume: 384 start-page: 129 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0655 article-title: Sotagliflozin in patients with diabetes and chronic kidney disease publication-title: N Engl J Med doi: 10.1056/NEJMoa2030186 contributor: fullname: Bhatt – volume: 293 start-page: E1274 year: 2007 ident: 10.1016/j.metabol.2021.154838_bb0355 article-title: Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00114.2007 contributor: fullname: Sommerfield – volume: 3 start-page: 693 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0580 article-title: Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2018.1717 contributor: fullname: Said – volume: 70 start-page: 847 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0490 article-title: Paradoxical associations of insulin resistance with total and cardiovascular mortality in humans publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glu194 contributor: fullname: Kim – volume: 388 start-page: 761 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0560 article-title: Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study publication-title: Lancet. doi: 10.1016/S0140-6736(16)30506-2 contributor: fullname: O’Donnell – volume: 377 start-page: 644 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0625 article-title: Canagliflozin and cardiovascular and renal events in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1611925 contributor: fullname: Neal – volume: 373 start-page: 2247 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0660 article-title: Lixisenatide in patients with type 2 diabetes and acute coronary syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa1509225 contributor: fullname: Pfeffer – volume: 8 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0015 article-title: The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis publication-title: PLoS One contributor: fullname: Singh – volume: 376 start-page: 1407 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0080 article-title: Mortality and cardiovascular disease in type 1 and type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1608664 contributor: fullname: Rawshani – volume: 40 start-page: 687 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0235 article-title: Genetically driven hyperglycemia increases risk of coronary artery disease separately from type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc16-2625 contributor: fullname: Merino – volume: 19 start-page: 69 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0710 article-title: Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial publication-title: Eur J Heart Fail doi: 10.1002/ejhf.657 contributor: fullname: Jorsal – volume: 71 start-page: 2867 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0035 article-title: Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.04.027 contributor: fullname: Liu – volume: 380 start-page: 347 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0640 article-title: Dapagliflozin and cardiovascular outcomes in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1812389 contributor: fullname: Wiviott – volume: 375 start-page: 311 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0670 article-title: Liraglutide and cardiovascular outcomes in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1603827 contributor: fullname: Marso – volume: 33 start-page: 1389 year: 2010 ident: 10.1016/j.metabol.2021.154838_bb0340 article-title: Hypoglycemia, diabetes, and cardiovascular events publication-title: Diabetes Care doi: 10.2337/dc09-2082 contributor: fullname: Desouza – volume: 17 start-page: 330 year: 2012 ident: 10.1016/j.metabol.2021.154838_bb0440 article-title: Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease publication-title: Vasc Med doi: 10.1177/1358863X12450094 contributor: fullname: Zhou – volume: 56 start-page: 2601 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0095 article-title: Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study publication-title: Diabetologia. doi: 10.1007/s00125-013-3063-1 contributor: fullname: Lind – volume: 317 start-page: 280 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0170 article-title: Association between diabetes and cause-specific mortality in rural and urban areas of China publication-title: Jama. doi: 10.1001/jama.2016.19720 contributor: fullname: Bragg – volume: 391 start-page: 2430 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0090 article-title: Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data publication-title: Lancet. doi: 10.1016/S0140-6736(18)30314-3 contributor: fullname: Gregg – volume: 42 start-page: S61 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0285 article-title: 6. Glycemic targets: standards of medical care in diabetes-2019 publication-title: Diabetes Care doi: 10.2337/dc19-S006 – volume: 43 start-page: 410 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0065 article-title: Asian subpopulations may exhibit greater cardiovascular benefit from long-acting glucagon-like peptide 1 receptor agonists: a meta-analysis of cardiovascular outcome trials publication-title: Diabetes Metab J doi: 10.4093/dmj.2018.0070 contributor: fullname: Kang – volume: 40 start-page: 1409 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0145 article-title: 2017 national standards for diabetes self-management education and support publication-title: Diabetes Care doi: 10.2337/dci17-0025 contributor: fullname: Beck – volume: 43 start-page: 1929 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0515 article-title: Individual and combined associations of modifiable lifestyle and metabolic health status with new-onset diabetes and major cardiovascular events: the China Cardiometabolic Disease and Cancer Cohort (4C) study publication-title: Diabetes Care doi: 10.2337/dc20-0256 contributor: fullname: Li – volume: 377 start-page: 1228 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0675 article-title: Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1612917 contributor: fullname: Holman – volume: 49 start-page: 1392 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0205 article-title: Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease publication-title: Nat Genet doi: 10.1038/ng.3914 contributor: fullname: Klarin – volume: 280 start-page: 1843 year: 1998 ident: 10.1016/j.metabol.2021.154838_bb0520 article-title: Abdominal adiposity and coronary heart disease in women publication-title: Jama. doi: 10.1001/jama.280.21.1843 contributor: fullname: Rexrode – volume: 72 start-page: 1763 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0705 article-title: Genetic variants in SGLT1, glucose tolerance, and cardiometabolic risk publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.07.061 contributor: fullname: Seidelmann – volume: 50 start-page: 1505 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0195 article-title: Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps publication-title: Nat Genet doi: 10.1038/s41588-018-0241-6 contributor: fullname: Mahajan – volume: 10 start-page: 1545 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0370 article-title: Development and validation of a risk prediction model for severe hypoglycemia in adult patients with type 2 diabetes: a nationwide population-based cohort study publication-title: Clin Epidemiol doi: 10.2147/CLEP.S169835 contributor: fullname: Han – volume: 381 start-page: 841 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0690 article-title: Oral Semaglutide and cardiovascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1901118 contributor: fullname: Husain – volume: 132 start-page: 997 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0175 article-title: Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.015293 contributor: fullname: Wilmot – volume: 6 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0600 article-title: Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis publication-title: Open Heart doi: 10.1136/openhrt-2019-001017 contributor: fullname: Shariful Islam – volume: 33 start-page: 1179 year: 2010 ident: 10.1016/j.metabol.2021.154838_bb0480 article-title: Insulin resistance predicts mortality in nondiabetic individuals in the U.S. publication-title: Diabetes Care doi: 10.2337/dc09-2110 contributor: fullname: Ausk – volume: 34 start-page: 1651 year: 2011 ident: 10.1016/j.metabol.2021.154838_bb0150 article-title: Diabetes performance measures: current status and future directions publication-title: Diabetes Care doi: 10.2337/dc11-0735 contributor: fullname: O’Connor – volume: 41 start-page: 917 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0010 article-title: Economic costs of diabetes in the U.S. in 2017 publication-title: Diabetes Care doi: 10.2337/dci18-0007 – volume: 11 start-page: 895 year: 2003 ident: 10.1016/j.metabol.2021.154838_bb0510 article-title: Waist circumference, BMI, smoking, and mortality in middle-aged men and women publication-title: Obes Res doi: 10.1038/oby.2003.123 contributor: fullname: Bigaard – volume: 25 start-page: 1135 year: 2002 ident: 10.1016/j.metabol.2021.154838_bb0375 article-title: HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study publication-title: Diabetes Care doi: 10.2337/diacare.25.7.1135 contributor: fullname: Bonora – volume: 68 start-page: 1370 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0310 article-title: Severe hypoglycemia and elevated high-sensitivity cardiac troponin T in older adults with diabetes: the ARIC study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.06.049 contributor: fullname: Lee – volume: 28 start-page: 527 year: 2010 ident: 10.1016/j.metabol.2021.154838_bb0450 article-title: Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation publication-title: J Hypertens doi: 10.1097/HJH.0b013e3283340da8 contributor: fullname: Zhou – volume: 64 start-page: 472 year: 2014 ident: 10.1016/j.metabol.2021.154838_bb0550 article-title: Leisure-time running reduces all-cause and cardiovascular mortality risk publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.04.058 contributor: fullname: Lee – volume: 381 start-page: 1995 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0630 article-title: Dapagliflozin in patients with heart failure and reduced ejection fraction publication-title: N Engl J Med doi: 10.1056/NEJMoa1911303 contributor: fullname: McMurray – volume: 6 start-page: 148 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0130 article-title: Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2020.4511 contributor: fullname: McGuire – volume: 89 start-page: 382 year: 2014 ident: 10.1016/j.metabol.2021.154838_bb0545 article-title: Alcohol and cardiovascular health: the dose makes the poison…or the remedy publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2013.11.005 contributor: fullname: O’Keefe – volume: 42 start-page: 777 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0590 article-title: Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial publication-title: Diabetes Care doi: 10.2337/dc18-0836 contributor: fullname: Salas-Salvadó – volume: 368 start-page: 1651 year: 2006 ident: 10.1016/j.metabol.2021.154838_bb0020 article-title: Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment publication-title: Lancet. doi: 10.1016/S0140-6736(06)69700-6 contributor: fullname: Danaei – volume: 358 start-page: 580 year: 2008 ident: 10.1016/j.metabol.2021.154838_bb0135 article-title: Effect of a multifactorial intervention on mortality in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa0706245 contributor: fullname: Gaede – volume: 44 start-page: 248 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0300 article-title: Severe hypoglycemia, cardiac structure and function, and risk of cardiovascular events among older adults with diabetes publication-title: Diabetes Care doi: 10.2337/dc20-0552 contributor: fullname: Echouffo-Tcheugui – start-page: 1 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0570 article-title: Smart wearable devices in cardiovascular care: where we are and how to move forward publication-title: Nat Rev Cardiol contributor: fullname: Bayoumy – volume: 45 start-page: 120 year: 2021 ident: 10.1016/j.metabol.2021.154838_bb0105 article-title: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea publication-title: Diabetes Metab J doi: 10.4093/dmj.2020.0175 contributor: fullname: Park – volume: 69 start-page: 112 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0180 article-title: Interaction between type 2 diabetes prevention strategies and genetic determinants of coronary artery disease on cardiometabolic risk factors publication-title: Diabetes. doi: 10.2337/db19-0097 contributor: fullname: Merino – volume: 8 start-page: 616 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0405 article-title: Causes, consequences, and treatment of metabolically unhealthy fat distribution publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(20)30110-8 contributor: fullname: Stefan – volume: 9 start-page: 238 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0445 article-title: Role of renin-angiotensin-aldosterone system in metabolic syndrome and obesity-related hypertension publication-title: Curr Hypertens Rev doi: 10.2174/1573402110666140812122349 contributor: fullname: Kamide – volume: 58 start-page: 443 year: 2009 ident: 10.1016/j.metabol.2021.154838_bb0350 article-title: Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects publication-title: Metabolism. doi: 10.1016/j.metabol.2008.10.018 contributor: fullname: Razavi Nematollahi – volume: 145 start-page: 341 year: 2011 ident: 10.1016/j.metabol.2021.154838_bb0415 article-title: Macrophages in the pathogenesis of atherosclerosis publication-title: Cell. doi: 10.1016/j.cell.2011.04.005 contributor: fullname: Moore – volume: 36 start-page: 1703 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0495 article-title: Relationship of insulin resistance to prevalence and progression of coronary artery calcification beyond metabolic syndrome components: Shiga epidemiological study of subclinical atherosclerosis publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.116.307612 contributor: fullname: Yamazoe – volume: 41 start-page: 348 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0210 article-title: Modulation of GLP-1 levels by a genetic variant that regulates the cardiovascular effects of intensive glycemic control in ACCORD publication-title: Diabetes Care doi: 10.2337/dc17-1638 contributor: fullname: Shah – volume: 52 start-page: 231 year: 2008 ident: 10.1016/j.metabol.2021.154838_bb0505 article-title: Adipokines, insulin resistance, and coronary artery calcification publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.04.016 contributor: fullname: Qasim – volume: 26 start-page: 1513 year: 2003 ident: 10.1016/j.metabol.2021.154838_bb0470 article-title: Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT) publication-title: Diabetes Care doi: 10.2337/diacare.26.5.1513 contributor: fullname: Robins – volume: 18 start-page: 103 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0320 article-title: Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-019-0909-y contributor: fullname: Yun – volume: 40 start-page: 468 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0125 article-title: Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013 publication-title: Diabetes Care doi: 10.2337/dc16-0985 contributor: fullname: Lipska – volume: 6 start-page: 7060 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0230 article-title: A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease publication-title: Nat Commun doi: 10.1038/ncomms8060 contributor: fullname: Ahmad – volume: 316 start-page: 500 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0715 article-title: Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial publication-title: Jama. doi: 10.1001/jama.2016.10260 contributor: fullname: Margulies – volume: 14 start-page: 11 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0190 article-title: Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes publication-title: BMC Med Genet doi: 10.1186/1471-2350-14-11 contributor: fullname: Rivera – volume: 41 start-page: 2306 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0110 article-title: Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes, 1988-2015 publication-title: Diabetes Care doi: 10.2337/dc18-0831 contributor: fullname: Cheng – volume: 379 start-page: 633 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0115 article-title: Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1800256 contributor: fullname: Rawshani – volume: 34 start-page: 3137 year: 2013 ident: 10.1016/j.metabol.2021.154838_bb0325 article-title: Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial publication-title: Eur Heart J doi: 10.1093/eurheartj/eht332 contributor: fullname: Mellbin – volume: 394 start-page: 121 year: 2019 ident: 10.1016/j.metabol.2021.154838_bb0685 article-title: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial publication-title: Lancet. doi: 10.1016/S0140-6736(19)31149-3 contributor: fullname: Gerstein – volume: 142 start-page: 1925 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0120 article-title: Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.120.046783 contributor: fullname: Wright – volume: 22 start-page: 196 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0725 article-title: European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure publication-title: Eur J Heart Fail doi: 10.1002/ejhf.1673 contributor: fullname: Seferović – volume: 54 start-page: 3252 year: 2005 ident: 10.1016/j.metabol.2021.154838_bb0475 article-title: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study publication-title: Diabetes. doi: 10.2337/diabetes.54.11.3252 contributor: fullname: Rutter – volume: 122 start-page: 433 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0200 article-title: Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease publication-title: Circ Res doi: 10.1161/CIRCRESAHA.117.312086 contributor: fullname: van der Harst – volume: 27 start-page: 1133 year: 2008 ident: 10.1016/j.metabol.2021.154838_bb0220 article-title: Mendelian randomization: using genes as instruments for making causal inferences in epidemiology publication-title: Stat Med doi: 10.1002/sim.3034 contributor: fullname: Lawlor – volume: 124 start-page: 967 year: 2011 ident: 10.1016/j.metabol.2021.154838_bb0565 article-title: Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association publication-title: Circulation. doi: 10.1161/CIR.0b013e3182285a81 contributor: fullname: Weintraub – volume: 5 year: 2016 ident: 10.1016/j.metabol.2021.154838_bb0305 article-title: Association between severe hypoglycemia and cardiovascular disease risk in Japanese patients with type 2 diabetes publication-title: J Am Heart Assoc doi: 10.1161/JAHA.115.002875 contributor: fullname: Goto – volume: 61 start-page: 58 year: 2018 ident: 10.1016/j.metabol.2021.154838_bb0335 article-title: DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality publication-title: Diabetologia. doi: 10.1007/s00125-017-4422-0 contributor: fullname: Pieber – volume: 26 start-page: 1086 year: 2006 ident: 10.1016/j.metabol.2021.154838_bb0460 article-title: Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000215951.36219.a4 contributor: fullname: de Jager – volume: 16 start-page: 1 year: 2017 ident: 10.1016/j.metabol.2021.154838_bb0100 article-title: Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013) publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-016-0482-6 contributor: fullname: Jung – volume: 36 start-page: 421 year: 2003 ident: 10.1016/j.metabol.2021.154838_bb0430 article-title: Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity publication-title: Clin Biochem doi: 10.1016/S0009-9120(03)00078-X contributor: fullname: Rashid – volume: 64 start-page: 673 year: 2015 ident: 10.1016/j.metabol.2021.154838_bb0535 article-title: Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes publication-title: Diabetes. doi: 10.2337/db14-0694 contributor: fullname: Nolan – volume: 34 start-page: 509 year: 2014 ident: 10.1016/j.metabol.2021.154838_bb0540 article-title: Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.113.300156 contributor: fullname: Messner – volume: 383 start-page: 1425 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0645 article-title: Cardiovascular outcomes with Ertugliflozin in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa2004967 contributor: fullname: Cannon – volume: 29 start-page: 329 year: 2006 ident: 10.1016/j.metabol.2021.154838_bb0465 article-title: High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study publication-title: Diabetes Care doi: 10.2337/diacare.29.02.06.dc05-1700 contributor: fullname: Soinio – volume: 395 start-page: 795 year: 2020 ident: 10.1016/j.metabol.2021.154838_bb0050 article-title: Modifiable risk factors, cardiovascular disease, and mortality in 155722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study publication-title: Lancet. doi: 10.1016/S0140-6736(19)32008-2 contributor: fullname: Yusuf |
SSID | ssj0007786 |
Score | 2.6346295 |
SecondaryResourceType | review_article |
Snippet | With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) has been decreasing... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 154838 |
SubjectTerms | Cardiovascular disease Cardiovascular Diseases - complications Cardiovascular Diseases - epidemiology Cardiovascular Diseases - genetics Cardiovascular Diseases - prevention & control Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - diet therapy Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - genetics Genetics Heart Disease Risk Factors Humans Hypoglycaemia Hypoglycemic Agents - therapeutic use Insulin Resistance Life Style Lifestyle modification Risk Management Type 2 diabetes |
Title | Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes |
URI | https://dx.doi.org/10.1016/j.metabol.2021.154838 https://www.ncbi.nlm.nih.gov/pubmed/34333002 https://search.proquest.com/docview/2557543680 |
Volume | 123 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EUbyIb9cXEbx2t01i0j2KKKuiJwVvoXkUVrC7aD148bc706YuiiJ4a_oMM9PJTOabGYBjLUuVyhCSLOTDRCrv8Zfi5KpoXLBFabWnfOebWzW6l1cPJw9zcNblwhCsMur-Vqc32jqeGURqDqbjMeX4oi2O9j3PmnAb1QSVOECZ7r_PYB5UH62FeaDnjHfPsngGj_2nUCOpKQLBM9pjySlN5ef16Tf7s1mHLlZhJRqQ7LSd4xrMhWodFtuWkm_rsHQTg-UbUMXaS6xucK9sXLEw6wf7xiYlc1_QqCxGa1hR-e-XCILOnj6xMvQy2r1lnHW7t5twf3F-dzZKYnuFxMmM14nPXYHGjMh8nnqHjlaqirIouSh94LLU3OZcp5bjkVZyKJQsqEGotdLlQlohtmC-mlRhB1hwwZFh5tAakHmhhqVVhXRaeBusGuoe9DuimmlbRcN08LJHE7lgiAum5UIP8o705os4GNT0fz161LHK4K9C8Y-iCpPXF4Pekz6hivtpD7ZbHn7ORkghBArJ7v8_vAfLNGqRfvswXz-_hgO0WGp72IjkISycXl6Pbj8AjWLqqw |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB60xcdFfFufEbyu3U3SZHssYmnV9qTgLWweCy24FV0P_nsz3WxFUQRvy4bshplk8k3mmwnAheS5iLlzUeLSbsSFtX5JUXRVpN-wWa6lxXzn0VgMHvjNY-dxCa7qXBikVQbbX9n0ubUOb9pBmu3nyQRzfD0W9_ieJvNwG1-GJu_IhDeg2RveDsYLg4wl0iqmh3eefYfPRJ729PLJlV7aGISgCR6zpJip8vMW9RsEnW9F_U3YCBiS9KphbsGSK7ZhpbpV8n0bVkchXr4DRSi_RMo59ZVMCuI-r4R9J7OcmC-EVBICNiQr7PcmZKGTpwVdBj-GB7iEkvoAdxce-tf3V4Mo3LAQGZ7QMrKpyTyeYYlNY2u8rxWLLM9yynLrKM8l1SmVsab-SQreZYJneEeo1tykjGvG9qBRzAp3AMQZZxCbGQ8IeJqJbq5Fxo1kVjsturIFl7VQ1XNVSEPVDLOpClpQqAVVaaEFaS169WVGKG_s_-p6XqtK-dWCIZCscLO3V-UdKNnBovtxC_YrHS5GwzhjzE-Sw___-AzWBvejO3U3HN8ewTq2VMS_Y2iUL2_uxAOYUp-GCfoBqYLtYQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+trends+in+epidemiology+of+cardiovascular+disease+and+cardiovascular+risk+management+in+type+2+diabetes&rft.jtitle=Metabolism%2C+clinical+and+experimental&rft.au=Yun%2C+Jae-Seung&rft.au=Ko%2C+Seung-Hyun&rft.date=2021-10-01&rft.issn=0026-0495&rft.volume=123&rft.spage=154838&rft_id=info:doi/10.1016%2Fj.metabol.2021.154838&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_metabol_2021_154838 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0026-0495&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0026-0495&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0026-0495&client=summon |